<!DOCTYPE article PUBLIC "-//NLM//DTD Journal Archiving and Interchange DTD v3.0 20080202//EN" "http://dtd.nlm.nih.gov/archiving/3.0/archivearticle3.dtd"><article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="research-article"><?properties open_access?><front><journal-meta><journal-id journal-id-type="nlm-ta">J Exp Med</journal-id><journal-id journal-id-type="hwp">jem</journal-id><journal-title-group><journal-title>The Journal of Experimental Medicine</journal-title></journal-title-group><issn pub-type="ppub">0022-1007</issn><issn pub-type="epub">1540-9538</issn><publisher><publisher-name>The Rockefeller University Press</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmid">19221396</article-id><article-id pub-id-type="publisher-id">20081886</article-id><article-id pub-id-type="doi">10.1084/jem.20081886</article-id><article-categories><subj-group subj-group-type="heading"><subject>Article</subject></subj-group></article-categories><title-group><article-title>Follicular helper T cells are required for systemic autoimmunity</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Linterman</surname><given-names>Michelle A.</given-names></name><xref ref-type="aff" rid="aff1">1</xref></contrib><contrib contrib-type="author"><name><surname>Rigby</surname><given-names>Robert J.</given-names></name><xref ref-type="aff" rid="aff1">1</xref></contrib><contrib contrib-type="author"><name><surname>Wong</surname><given-names>Raphael. K.</given-names></name><xref ref-type="aff" rid="aff1">1</xref></contrib><contrib contrib-type="author"><name><surname>Yu</surname><given-names>Di</given-names></name><xref ref-type="aff" rid="aff1">1</xref></contrib><contrib contrib-type="author"><name><surname>Brink</surname><given-names>Robert</given-names></name><xref ref-type="aff" rid="aff2">2</xref></contrib><contrib contrib-type="author"><name><surname>Cannons</surname><given-names>Jennifer L.</given-names></name><xref ref-type="aff" rid="aff3">3</xref></contrib><contrib contrib-type="author"><name><surname>Schwartzberg</surname><given-names>Pamela L.</given-names></name><xref ref-type="aff" rid="aff3">3</xref></contrib><contrib contrib-type="author"><name><surname>Cook</surname><given-names>Matthew C.</given-names></name><xref ref-type="aff" rid="aff4">4</xref><xref ref-type="aff" rid="aff5">6</xref></contrib><contrib contrib-type="author"><name><surname>Walters</surname><given-names>Giles D.</given-names></name><xref ref-type="aff" rid="aff4">5</xref><xref ref-type="aff" rid="aff5">6</xref></contrib><contrib contrib-type="author" corresp="yes"><name><surname>Vinuesa</surname><given-names>Carola G.</given-names></name><xref ref-type="aff" rid="aff1">1</xref></contrib></contrib-group><aff id="aff1"><label>1</label><institution>Division of Immunology and Genetics, The John Curtin School of Medical Research, Australian National University, Canberra, ACT 2601, Australia</institution></aff><aff id="aff2"><label>2</label><institution>Garvan Institute of Medical Research, Sydney, NSW 2010, Australia</institution></aff><aff id="aff3"><label>3</label><institution>National Human Genome Research Institute, National Institutes of Health, Bethesda, MD 20892</institution></aff><aff id="aff4"><label>4</label><institution>Department of Immunology</institution> and <label>5</label><institution>Department of Renal Medicine, The Canberra Hospital, Canberra, ACT 2605, Australia</institution></aff><aff id="aff5"><label>6</label><institution>Australian National University Medical School, Canberra, ACT 2605, Australia</institution></aff><author-notes><corresp>CORRESPONDENCE Carola G Vinuesa: <email>carola.vinuesa@anu.edu.au</email></corresp></author-notes><pub-date pub-type="ppub"><day>16</day><month>3</month><year>2009</year></pub-date><volume>206</volume><issue>3</issue><fpage>561</fpage><lpage>576</lpage><history><date date-type="received"><day>21</day><month>8</month><year>2008</year></date><date date-type="accepted"><day>22</day><month>1</month><year>2009</year></date></history><permissions><copyright-statement>&#x000a9; 2009 Linterman et al.</copyright-statement><copyright-year>2009</copyright-year><license license-type="openaccess" xlink:href="http://creativecommons.org/licenses/by/2.0/"><license-p>This article is distributed under the terms of an Attribution&#x02013;Noncommercial&#x02013;Share Alike&#x02013;No Mirror Sites license for the first six months after the publication date (see <ext-link ext-link-type="uri" xlink:href="http://www.jem.org/misc/terms.shtml">http://www.jem.org/misc/terms.shtml</ext-link>). After six months it is available under a Creative Commons License (Attribution&#x02013;Noncommercial&#x02013;Share Alike 3.0 Unported license, as described at <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by-nc-sa/3.0/">http://creativecommons.org/licenses/by-nc-sa/3.0/</ext-link>).</license-p></license></permissions><abstract><p>Production of high-affinity pathogenic autoantibodies appears to be central to the pathogenesis of lupus. Because normal high-affinity antibodies arise from germinal centers (GCs), aberrant selection of GC B cells, caused by either failure of negative selection or enhanced positive selection by follicular helper T (T<sub>FH</sub>) cells, is a plausible explanation for these autoantibodies. Mice homozygous for the <italic>san</italic> allele of <italic>Roquin,</italic> which encodes a RING-type ubiquitin ligase, develop GCs in the absence of foreign antigen, excessive T<sub>FH</sub> cell numbers, and features of lupus. We postulated a positive selection defect in GCs to account for autoantibodies. We first demonstrate that autoimmunity in <italic>Roquin<sup>san/san</sup></italic> (<italic>sanroque</italic>) mice is GC dependent: deletion of one allele of <italic>Bcl6</italic> specifically reduces the number of GC cells, ameliorating pathology. We show that Roquin<italic><sup>san</sup></italic> acts autonomously to cause accumulation of T<sub>FH</sub> cells. Introduction of a null allele of the signaling lymphocyte activation molecule family adaptor <italic>Sap</italic> into the <italic>sanroque</italic> background resulted in a substantial and selective reduction in <italic>sanroque</italic> T<sub>FH</sub> cells, and abrogated formation of GCs, autoantibody formation, and renal pathology. In contrast, adoptive transfer of <italic>sanroque</italic> T<sub>FH</sub> cells led to spontaneous GC formation. These findings identify T<sub>FH</sub> dysfunction within GCs and aberrant positive selection as a pathway to systemic autoimmunity.</p></abstract></article-meta></front><body><p>Systemic lupus erythematosus (SLE) is the prototypic systemic autoimmune disorder. With highly variable clinical manifestations and only 4 out of 11 criteria required to establish the diagnosis (<xref ref-type="bibr" rid="bib1">1</xref>), multiple pathogenic pathways are likely to contribute to end-organ damage in this disease. Elucidating the different pathways that lead to lupus in particular subsets of patients and identifying biomarkers that flag the different pathways is essential to design more specific and effective therapies.</p><p>The formation of autoantibodies against cell nuclear components, including double-stranded DNA (dsDNA), ribonuclear proteins, and histones, is a consistent feature and therefore likely to be fundamental to the disease. This is supported by the observation that formation of autoantibodies precedes development of clinical manifestations of lupus (<xref ref-type="bibr" rid="bib2">2</xref>), evidence that some of these antibodies contribute to end-organ damage, and the efficacy of B cell&#x02013;depleting therapy with rituximab (<xref ref-type="bibr" rid="bib3">3</xref>). Identification of defects that result in autoantibody formation is therefore of considerable importance in understanding the pathogenesis of lupus.</p><p>Numerous engineered and spontaneous defects in central and peripheral tolerance result in antinuclear antibodies (ANAs). However, the specificity and high affinity of the autoantibody response in lupus points to a defect in the response to self-antigen in the periphery. During T-dependent responses, activated B cells receive help from T cells in the T cell zones of secondary lymphoid tissues, and differentiate either extrafollicularly into short-lived plasma cells that produce low-affinity antibody, or enter the follicular pathway and form germinal centers (GCs) (<xref ref-type="bibr" rid="bib4">4</xref>). Within this microenvironment, B cells undergo somatic hypermutation (SHM) and isotype switching, resulting in the generation of memory B cells and long-lived plasma cells that secrete high-affinity antigen-specific IgG antibodies (<xref ref-type="bibr" rid="bib5">5</xref>, <xref ref-type="bibr" rid="bib6">6</xref>). Selection of mutated high-affinity GC B cells depends on restimulation with antigen arrayed on follicular dendritic cells and provision of help by follicular T helper (T<sub>FH</sub>) cells.</p><p>Because SHM has the potential to generate self-reactive antibodies (<xref ref-type="bibr" rid="bib7">7</xref>), it has been long thought that aberrant selection within GCs represents a candidate pathway to the production of lupus-associated autoantibodies. Indeed, autoantibodies detected in SLE patients and mouse lupus models are generally high affinity and somatically mutated (<xref ref-type="bibr" rid="bib7">7</xref>, <xref ref-type="bibr" rid="bib8">8</xref>). Exclusion of self-reactive B cells from GCs has been shown to be defective in SLE patients. Also, GCs have been shown to form spontaneously in several different mouse models of lupus (<xref ref-type="bibr" rid="bib9">9</xref>), and these are rich in apoptotic cells displaying the antigenic targets of lupus autoimmunity (<xref ref-type="bibr" rid="bib10">10</xref>, <xref ref-type="bibr" rid="bib11">11</xref>). Although SHM can occur outside GCs, this process is far less efficient (<xref ref-type="bibr" rid="bib12">12</xref>, <xref ref-type="bibr" rid="bib13">13</xref>). Despite all of this circumstantial evidence, there is to date no definite proof that GCs and/or T<sub>FH</sub> cells are directly required for the production of lupus autoantibodies or end-organ damage. In contrast, extrafollicular affinity maturation of autoantibodies to dsDNA in MRL<italic><sup>lpr</sup></italic> mice (<xref ref-type="bibr" rid="bib14">14</xref>, <xref ref-type="bibr" rid="bib15">15</xref>) and T-independent B cell activating factor of the TNF family&#x02013;driven pathways to lupus have been demonstrated (<xref ref-type="bibr" rid="bib16">16</xref>, <xref ref-type="bibr" rid="bib17">17</xref>).</p><p>Furthermore, the prevailing model is that within GCs, autoantibodies might arise because of defects in negative rather than positive selection, because GC B cells are programmed to undergo apoptosis by default if they do not receive T cell selection signals. This is consistent with evidence that centrocytes down-regulate apoptosis inhibitors such as Bcl-2 and Bcl-xL while up-regulating proapoptotic molecules such as Fas and Bim (<xref ref-type="bibr" rid="bib18">18</xref>). Normally, a dedicated population of T<sub>FH</sub> cells is thought to provide help during selection of GC B cells (<xref ref-type="bibr" rid="bib19">19</xref>, <xref ref-type="bibr" rid="bib20">20</xref>), and indeed a correlation between increased numbers of T<sub>FH</sub> cells and autoimmunity has been described in mouse models of lupus (<xref ref-type="bibr" rid="bib21">21</xref>, <xref ref-type="bibr" rid="bib22">22</xref>), suggesting that defects in positive selection by T<sub>FH</sub> cells might indeed lead to lupus. Although recent evidence has suggested that Th17 cells may be responsible for aberrant selection of self-reactive GC B cells and autoantibody formation in BXD2 mice (<xref ref-type="bibr" rid="bib23">23</xref>), direct evidence that T<sub>FH</sub> cells can drive autoimmunity has not been provided.</p><p>The <italic>sanroque</italic> strain was discovered from screening an ENU mutagenized mouse library for autoimmune regulators (<xref ref-type="bibr" rid="bib24">24</xref>), and exhibits a lupus-like phenotype characterized by high-affinity anti-dsDNA antibodies, hypergammaglobulinemia, lymphanedopathy, splenomegaly, autoimmune thrombocytopenia, and glomerulonephritis with IgG-containing immune complex deposits. Both the autoimmunity and cellular characteristics of <italic>sanroque</italic> segregate with homozygosity for the <italic>san</italic> allele (M<sub>199</sub>R substitution) of <italic>Roquin</italic> (<italic>Roquin<sup>san/san</sup></italic>) (<xref ref-type="bibr" rid="bib22">22</xref>). Roquin has been demonstrated to be a regulator of the stability T cell messenger RNAs. Development of autoimmunity in <italic>Roquin<sup>san/san</sup></italic> mice also correlates with spontaneous GC formation, which is largely driven by B cell&#x02013;extrinsic factors (<xref ref-type="bibr" rid="bib22">22</xref>). <italic>Roquin<sup>san/san</sup></italic> mice have a marked accumulation of T cells within the B cell follicles, and the T<sub>FH</sub> subset is overrepresented within the CD4<sup>+</sup> cell compartment.</p><p>In this paper, we report that dysregulation of the GC response through excessive formation of T<sub>FH</sub> cells is responsible for autoimmunity in <italic>Roquin<sup>san/san</sup></italic> mice. Loss of one allele of <italic>Bcl6</italic>, the master transcriptional regulator of GCs (<xref ref-type="bibr" rid="bib25">25</xref>, <xref ref-type="bibr" rid="bib26">26</xref>), significantly reduces spontaneous GC formation in <italic>Roquin<sup>san/san</sup></italic> mice and the lupus phenotype. Furthermore, deletion of Sap (<italic>Sh2d1a</italic>) from <italic>Roquin<sup>san/san</sup></italic> mice causes a dramatic reduction of T<sub>FH</sub> cells and IL-21. Sap is a small adaptor protein necessary for signaling through the signaling lymphocyte activation molecule family cell-surface receptors that regulates signals downstream of the TCR. <italic>Roquin<sup>san/san</sup> Sap<sup>&#x02212;/&#x02212;</sup></italic> CD4<sup>+</sup> cells also express lower levels of ICOS than <italic>Roquin<sup>san/san</sup> Sap</italic><sup>+/+</sup> cells. This results in abrogation of ANAs (including anti-dsDNA) and end-stage renal disease. These findings establish a causal pathway from the <italic>san</italic> allele of <italic>Roquin</italic> to excess T<sub>FH</sub> formation, aberrant GC formation, and positive selection of pathogenic high-affinity autoantibodies to illuminate a novel pathway of lupus pathogenesis.</p><sec sec-type="results"><title>RESULTS</title><sec><title>Heterozygous Bcl6 deficiency reduces spontaneous GCs and attenuates autoimmunity in <italic>Roquin<sup>san/san</sup></italic> mice</title><p>BCL6 has been shown to be the master transcriptional regulator of GC B cells (<xref ref-type="bibr" rid="bib27">27</xref>). As BCL6 deficiency results in early mortality because of widespread inflammation, we investigated <italic>Bcl6</italic><sup>+/&#x02212;</sup> mice for possible defects in the GC response. 8 d after sheep red blood cell (SRBC) immunization, the percentage of GC cells was more than fivefold lower in mice heterozygous for <italic>Bcl6</italic> deficiency (2.3 &#x000b1; 0.59% vs. 0.43 &#x000b1; 0.46%; P = 0.0011; <xref ref-type="fig" rid="fig1">Fig. 1 a</xref>).</p><fig id="fig1" position="float"><label>Figure 1.</label><caption><p><bold>Heterozygosity for Bcl6 reduces the magnitude of the GC response in <italic>Roquin<sup>+/+</sup></italic> and <italic>Roquin<sup>san/san</sup></italic> mice and ameliorates the lupus-like phenotype of <italic>Roquin<sup>san/san</sup></italic> mice.</bold> (a) Flow cytometric contour plots (left) and graphical analysis (right) of B220<sup>+</sup>GL-7<sup>+</sup>CD95<sup>+</sup> GC B cells in 10-wk-old wild-type (<italic>Bcl6<sup>+/+</sup></italic>) and <italic>Bcl6<sup>+/&#x02212;</sup></italic> mice 8 d after SRBC immunization (P = 0.0011). Data are representative of four independent experiments (<italic>n</italic> = 4 per group). (b) Flow cytometric contour plots (left) and dot plots (right) showing B220<sup>+</sup>GL-7<sup>+</sup>CD95<sup>+</sup> GC B cells from 10-wk-old naive <italic>Roquin<sup>san/san</sup> Bcl6<sup>+/+</sup></italic> and <italic>Roquin<sup>san/san</sup> Bcl6<sup>+/&#x02212;</sup></italic> mice. Data are representative of five independent experiments (<italic>n</italic> &#x02265; 4 per group). (c) Representative determination of serum IgG anti-dsDNA from 6-mo-old female <italic>Roquin<sup>+/+</sup> Bcl6<sup>+/+</sup>, Roquin<sup>san/san</sup> Bcl6<sup>+/+</sup></italic>, and <italic>Roquin<sup>san/san</sup> Bcl6<sup>+/&#x02212;</sup></italic> mice, determined by immunofluorescence staining of <italic>C. luciliae</italic> substrate. Data shown reflect the occurrence (<italic>n</italic> &#x02265; 6 mice per group); three out of six <italic>Roquin<sup>san/san</sup> Bcl6<sup>+/&#x02212;</sup></italic> mice had low intensity staining (illustrated in the fourth panel from left), and three out of six were negative (illustrated in the third panel from left). (d) Representative images of kidney sections stained with H&#x00026;E (left) or viewed under an electron microscope (right) from 6-mo-old mice of the indicated genotypes. <italic>Roquin<sup>san/san</sup></italic> animals show widespread mesangial proliferative lesions with moderate interstitial infiltrate. There are multiple electron-dense deposits (arrows). Histological changes in <italic>Roquin<sup>san/san</sup> Bcl6<sup>+/&#x02212;</sup></italic> mice were mild, with occasional electron-dense deposits visible on electron microscopy in two individuals (far right). Images are representative (<italic>n</italic> &#x02265; 4 per group). Bars: (H&#x00026;E) 100 &#x000b5;m in all panels; (electron microscopy) 5 &#x000b5;m in the <italic>Roquin<sup>+/+</sup> Bcl6<sup>+/+</sup></italic> and <italic>Roquin<sup>san/san</sup> Bcl6<sup>+/+</sup></italic> panels, 2 &#x000b5;m in the left <italic>Roquin<sup>san/san</sup> Bcl6<sup>+/&#x02212;</sup></italic> panels, and 10 &#x000b5;m in the right <italic>Roquin<sup>san/san</sup> Bcl6<sup>+/&#x02212;</sup></italic> panel. (e) Nephritis severity score of 6-mo-old female <italic>Roquin<sup>+/+</sup></italic>, <italic>Roquin<sup>san/san</sup></italic>, and <italic>Roquin<sup>san/san</sup> Bcl6<sup>+/&#x02212;</sup></italic> mice as determined by histological analysis according to the criteria given in Table S1 (available at <ext-link ext-link-type="uri" xlink:href="http://www.jem.org/cgi/content/full/jem.20081886/DC1">http://www.jem.org/cgi/content/full/jem.20081886/DC1</ext-link>). Horizontal bars indicate medians. In a, b, and e, each symbol represents one mouse; p-values are indicated on the graphs, and the numbers in the plots represent percentages.</p></caption><graphic xlink:href="JEM_20081886_RGB_Fig1"/></fig><p>To determine whether <italic>Bcl6</italic> heterozygosity could curtail the spontaneous GC response in <italic>Roquin<sup>san/san</sup></italic> mice, we compared the percentage of GC cells in unimmunized <italic>Roquin<sup>san/san</sup> Bcl6</italic><sup>+/+</sup> and <italic>Roquin<sup>san/san</sup> Bcl6</italic><sup>+/&#x02212;</sup> mice. As seen in wild-type mice, loss of one allele of <italic>Bcl6</italic> caused a twofold reduction (4.4 &#x000b1; 1.9% vs. 2.1 &#x000b1; 0.5%; P = 0.0026) in the percentage of spontaneous GCs in <italic>Roquin<sup>san/san</sup></italic> mice (<xref ref-type="fig" rid="fig1">Fig. 1 b</xref>). Loss of one allele of Bcl-6 also reduced GC B cells after SRBC immunization in a cell-autonomous manner (Fig. S1, available at <ext-link ext-link-type="uri" xlink:href="http://www.jem.org/cgi/content/full/jem.20081886/DC1">http://www.jem.org/cgi/content/full/jem.20081886/DC1</ext-link>).</p><p>We then tested whether reduction in the spontaneous GC response in <italic>Roquin<sup>san/san</sup> Bcl6</italic><sup>+/&#x02212;</sup> mice was accompanied by reduced pathology. Serum dsDNA antibodies were present in 50% of <italic>Roquin<sup>san/san</sup> Bcl6</italic><sup>+/&#x02212;</sup> mice tested compared with 100% of <italic>Roquin<sup>san/san</sup> Bcl6</italic><sup>+/+</sup> mice (<xref ref-type="fig" rid="fig1">Fig. 1 c</xref>). Kidney pathology was also significantly reduced in <italic>Roquin<sup>san/san</sup> Bcl6</italic><sup>+/&#x02212;</sup> mice (<xref ref-type="fig" rid="fig1">Fig. 1, d and e</xref>).</p></sec><sec><title>The lupus-like pathology of <italic>Roquin<sup>san/san</sup></italic> mice requires T cell activation</title><p>We have previously demonstrated that Roquin acts predominantly B cell extrinsically to induce spontaneous GC formation, and T cell intrinsically to prevent accumulation of activated/memory T cells and repress ICOS expression (<xref ref-type="bibr" rid="bib22">22</xref>, <xref ref-type="bibr" rid="bib28">28</xref>). These findings suggest that the spontaneous GC reaction is driven by Roquin-mediated dysregulation of T cells. In a first attempt to confirm that <italic>Roquin<sup>san/san</sup></italic> lupus is T cell driven, we generated <italic>Roquin<sup>san/san</sup></italic> mice deficient in the major T cell co-stimulator CD28 (<italic>Cd28<sup>&#x02212;/&#x02212;</sup></italic> mice). Failure to prime T cells in <italic>Roquin<sup>san/san</sup> Cd28<sup>&#x02212;/&#x02212;</sup></italic> mice abrogated the production of antinuclear IgG, including high-affinity anti-dsDNA antibodies (<xref ref-type="fig" rid="fig2">Fig. 2 a</xref>). Both interstitial nephritis and glomerular pathology, characterized by increased mesangial cellularity and dense deposits observed in 6-mo-old <italic>Roquin<sup>san/san</sup></italic> mice, were substantially reduced in age-matched <italic>Roquin<sup>san/san</sup> Cd28<sup>&#x02212;/&#x02212;</sup></italic> mice, with only very mild interstitial nephritis (<xref ref-type="fig" rid="fig2">Fig. 2, b and c</xref>). Less than half of the <italic>Roquin<sup>san/san</sup> Cd28<sup>&#x02212;/&#x02212;</sup></italic> mice examined had low-grade mesangial immune complex deposits (<xref ref-type="fig" rid="fig2">Fig. 2 c</xref>). Of note, <italic>Roquin<sup>san/san</sup> Cd28<sup>&#x02212;/&#x02212;</sup></italic> naive CD4<sup>+</sup> T cells had a twofold decrease in ICOS expression (<xref ref-type="bibr" rid="bib29">29</xref>).</p><fig id="fig2" position="float"><label>Figure 2.</label><caption><p><bold>The autoimmune phenotype of <italic>Roquin<sup>san/san</sup></italic> mice requires T cell activation through CD28, and T<sub>FH</sub> cells are expanded cell autonomously.</bold> (a, left) Detection of IgG-ANA using Hep-2 slides in sera from 8-wk-old female <italic>Roquin<sup>san/san</sup></italic> and <italic>Roquin<sup>san/san</sup> Cd28<sup>&#x02212;/&#x02212;</sup></italic> mice (<italic>n</italic> = 5 per group). (right) Detection of anti-dsDNA IgG serum antibodies in 6-mo-old female <italic>Roquin<sup>san/san</sup></italic> and <italic>Roquin<sup>san/san</sup> Cd28<sup>&#x02212;/&#x02212;</sup></italic> mice determined by staining <italic>C. luciliae</italic> slides. Data are representative of three independent experiments (<italic>n</italic> &#x02265; 5 per group). (b) Score of nephritis severity in 6-mo-old female <italic>Roquin<sup>+/+</sup> Roquin<sup>san/san</sup></italic> and <italic>Roquin<sup>san/san</sup> Cd28<sup>&#x02212;/&#x02212;</sup></italic> mice as determined by histological analysis defined by the criteria given in Table S1 (available at <ext-link ext-link-type="uri" xlink:href="http://www.jem.org/cgi/content/full/jem.20081886/DC1">http://www.jem.org/cgi/content/full/jem.20081886/DC1</ext-link>). Each symbol represents one mouse. Horizontal bars indicate medians. (c) Representative images of kidney sections stained with H&#x00026;E (left) or viewed under an electron microscope (right). Histology from <italic>Roquin<sup>san/san</sup> Cd28<sup>&#x02212;/&#x02212;</sup></italic> animals was much less severe, with normal H&#x00026;E appearances and few electron-dense deposits (arrows) in the mesangium. Bars: (left) 100 &#x000b5;m; (right) 10 &#x000b5;m. (d) Representative flow cytometric contour plots of CD4<sup>+</sup>CXCR5<sup>+</sup>PD-1<sup>high</sup> T<sub>FH</sub> cells in 10-wk-old <italic>Roquin<sup>san/san</sup></italic> mice and control littermates. Data are representative of five independent experiments (<italic>n</italic> = 4 per group), and the numbers in the plots represent percentages. (e) Dot plots representing percentages of CD4<sup>+</sup>CXCR5<sup>+</sup>PD-1<sup>high</sup> T<sub>FH</sub> cells from SRBC-immunized chimeric mice generated by reconstituting sublethally irradiated mice with a 1:1 mix of either <italic>Roquin<sup>+/+</sup></italic>.Ly5<sup>a</sup>/<italic>Roquin<sup>+/+</sup></italic>.Ly5<sup>b</sup> (left) or <italic>Roquin<sup>+/+</sup></italic>.Ly5<sup>a</sup>/ <italic>Roquin<sup>san/san</sup></italic>.Ly5<sup>b</sup> (right). Data are representative of three independent experiments (<italic>n</italic> = 4 per group). Each symbol represents the Ly5<sup>a</sup> or Ly5<sup>b</sup> population derived from one mouse. (f) ELISA was used to determine culture supernatant IL-21 levels from 24-h splenocyte cultures from <italic>Roquin<sup>san/san</sup></italic> mice and littermate controls in the presence of PMA and ionomycin. Error bars indicate means &#x000b1; SEM. Data are representative of three independent tests where each sample was run in triplicate.</p></caption><graphic xlink:href="JEM_20081886_RGB_Fig2"/></fig></sec><sec><title>Expansion of the T<sub>FH</sub> subset in <italic>Roquin<sup>san/san</sup></italic> mice is T cell intrinsic</title><p>We have previously reported the similarity of the gene expression profiles of <italic>Roquin<sup>san/san</sup></italic> CD4<sup>+</sup> T cells and T<sub>FH</sub> cells. Furthermore, <italic>Roquin<sup>san/san</sup></italic> T cells accumulate in the splenic GCs (<xref ref-type="bibr" rid="bib22">22</xref>). To formally assess whether T<sub>FH</sub> cells, defined as CD4<sup>+</sup>CXCR5<sup>+</sup>PD-1<sup>high</sup> (<xref ref-type="bibr" rid="bib30">30</xref>), are expanded in <italic>Roquin<sup>san/san</sup></italic> mice, we analyzed the percentage and total number of these cells in unimmunized mice and found more than a threefold increase of this subset in <italic>Roquin<sup>san/san</sup></italic> mice compared with littermate controls (<xref ref-type="fig" rid="fig2">Fig. 2 d</xref>). To determine whether this aberrant T<sub>FH</sub> cell accumulation is cell intrinsic, we generated mixed chimeras. Sublethally irradiated <italic>Roquin</italic><sup>+/+</sup>Ly5<sup>a</sup> mice were reconstituted with a 1:1 mix of <italic>Roquin</italic><sup>+/+</sup>Ly5<sup>a</sup> and <italic>Roquin<sup>san/san</sup></italic>Ly5<sup>b</sup> bone marrow cells. As a control, <italic>Roquin</italic><sup>+/+</sup>Ly5<sup>a</sup> mice were reconstituted with a 1:1 mix of <italic>Roquin</italic><sup>+/+</sup>Ly5<sup>a</sup> and <italic>Roquin</italic><sup>+/+</sup>Ly5<sup>b</sup> bone marrow cells. 8 wk after reconstitution, mice were immunized with SRBCs, and the percentage of T<sub>FH</sub> cells derived from each type of donor marrow was determined by flow cytometry. In chimeras reconstituted with <italic>Roquin</italic><sup>+/+</sup>Ly5<sup>a</sup>/<italic>Roquin<sup>san/san</sup></italic>Ly5<sup>b</sup> marrow, three times more Ly5<sup>b</sup> (<italic>Roquin<sup>san/san</sup></italic>) T<sub>FH</sub> cells than Ly5<sup>a</sup> cells were observed (P = 0.001), whereas in controls, an equivalent proportion of T<sub>FH</sub> cells arose from Ly5<sup>a</sup> and Ly5<sup>b</sup> cells (P = 0.56; <xref ref-type="fig" rid="fig2">Fig. 2 e</xref>). This indicates that Roquin acts in T cells to repress the formation and/or survival of T<sub>FH</sub> cells. Consistent with the observed increase in T<sub>FH</sub> cell numbers, IL-21 production was more than twofold higher in splenocyte cultures from <italic>Roquin<sup>san/san</sup></italic> mice (<xref ref-type="fig" rid="fig2">Fig. 2 f</xref>).</p><p>Although T<sub>FH</sub> cells are expanded in <italic>Roquin<sup>san/san</sup></italic> mice, it was important to exclude defects in other T cell subsets implicated in autoimmunity. CD4<sup>+</sup>CD25<sup>+</sup>FoxP3<sup>+</sup> T reg cells have been shown to play a role in the regulation of lupus-associated autoantibodies (<xref ref-type="bibr" rid="bib31">31</xref>). T reg cells are not reduced in number or function in <italic>Roquin<sup>san/san</sup></italic> mice (<xref ref-type="bibr" rid="bib22">22</xref>). Quantification of FoxP3<sup>+</sup>CD25<sup>+</sup>CD4<sup>+</sup> cells in the spleen confirmed previous observations: <italic>Roquin<sup>san/san</sup></italic> mice have approximately twofold more T reg cells than wild-type mice (18.9 &#x000b1; 3.69% vs. 9.76 &#x000b1; 1.03%, respectively; Fig. S2 a, available at <ext-link ext-link-type="uri" xlink:href="http://www.jem.org/cgi/content/full/jem.20081886/DC1">http://www.jem.org/cgi/content/full/jem.20081886/DC1</ext-link>). This argues against a role for reduced T reg cell numbers in driving the T cell&#x02013;mediated disease of <italic>Roquin<sup>san/san</sup></italic> mice. Another T helper subset, Th17 cells, have emerged as potent mediators of autoimmunity (<xref ref-type="bibr" rid="bib31">31</xref>), and recent work suggests that they may be critical to maintain the spontaneous GCs of BXD2 mice (<xref ref-type="bibr" rid="bib23">23</xref>). To test whether Th17 cell activity is dysregulated in <italic>Roquin<sup>san/san</sup></italic> mice, we analyzed IL-17 levels in splenocyte cell cultures after activation with PMA and ionomycin. IL-17 was detected at comparable levels in cultures from <italic>Roquin</italic><sup>+/+</sup> and <italic>Roquin<sup>san/san</sup></italic> mice (Fig. S2 b). In contrast, IL-21, a cytokine secreted by both T<sub>FH</sub> and Th17 cells (<xref ref-type="bibr" rid="bib33">33</xref>, <xref ref-type="bibr" rid="bib34">34</xref>), was found at significantly higher levels in <italic>Roquin<sup>san/san</sup></italic> splenocyte cultures (<xref ref-type="fig" rid="fig2">Fig. 2 f</xref>). Collectively these data indicate that the T<sub>FH</sub> subset in <italic>Roquin<sup>san/san</sup></italic> mice is expanded in a cell-autonomous manner, whereas T reg and Th17 cells do not appear to be dysregulated in a way that has been previously described to result in autoimmunity.</p></sec><sec><title>SAP-deficient mice form reduced numbers of T<sub>FH</sub> cells</title><p>Having established that Roquin acts T cell intrinsically to dysregulate T<sub>FH</sub> cell numbers leading to the formation of abundant GCs, we hypothesized that disrupting the GC reaction through selective reduction of T<sub>FH</sub> cell numbers or function would attenuate systemic autoimmunity. SAP is an adaptor protein necessary for signaling through the signaling lymphocyte activation molecule family receptors that regulates signals downstream of the TCR. Mice lacking SAP cannot form GCs or generate immunological memory after immunization, a result of impaired CD4<sup>+</sup> T cell help to GC B cells after antigen exposure (<xref ref-type="bibr" rid="bib35">35</xref>&#x02013;<xref ref-type="bibr" rid="bib38">38</xref>). To date, it is not known whether SAP signaling is also required to maintain optimal T<sub>FH</sub> cell numbers. We enumerated CD4<sup>+</sup>CXCR5<sup>+</sup>PD-1<sup>high</sup> T<sub>FH</sub> cells in SAP-deficient unimmunized mice and wild-type littermates, and observed a twofold decrease in the number of basal T<sub>FH</sub> cells (<xref ref-type="fig" rid="fig3">Fig. 3 a</xref>, left). This was accompanied by a fourfold reduction in the number of background GC B cells (<xref ref-type="fig" rid="fig3">Fig. 3 b</xref>, right).</p><fig id="fig3" position="float"><label>Figure 3.</label><caption><p><bold>Spontaneous GC and T<sub>FH</sub> formation are corrected by loss of SAP in <italic>Roquin<sup>san/san</sup></italic> mice.</bold> (a) CD4<sup>+</sup>CXCR5<sup>+</sup>PD-1<sup>high</sup> T<sub>FH</sub> cells in unimmunized 10-wk-old <italic>Roquin<sup>san/san</sup></italic> and <italic>Roquin<sup>san/san</sup> Sap<sup>&#x02212;/&#x02212;</sup></italic> mice (P = 0.0056). Representative flow cytometric contour plots are shown (right). Data are representative of four independent experiments (<italic>n</italic> = 4 per group). (b) B220<sup>+</sup>GL-7<sup>+</sup>CD95<sup>+</sup> GC B cells in unimmunized 10-wk-old <italic>Roquin<sup>san/san</sup> Sap<sup>+/+</sup></italic> and <italic>Roquin<sup>san/san</sup> Sap<sup>&#x02212;/&#x02212;</sup></italic> mice (P = 0.0007). Representative flow cytometric contour plots are shown (right). Data are representative of four independent experiments (<italic>n</italic> = 4 per group). (c) Photomicrographs of frozen spleen sections from unimmunized 6-mo-old mice of the indicated genotypes stained with IgD (brown; all panels), PNA (blue; left), TCR&#x003b2; (blue; middle), and PD-1 (blue; right). Bars, 200 &#x000b5;m.</p></caption><graphic xlink:href="JEM_20081886_RGB_Fig3"/></fig></sec><sec><title><italic>Roquin<sup>san/san</sup> Sap<sup>&#x02212;/&#x02212;</sup></italic> mice do not form excessive T<sub>FH</sub> cells or spontaneous GCs</title><p>Once we had established that SAP deficiency not only impairs CD4<sup>+</sup> T cell help for GC B cells but also decreases T<sub>FH</sub> cell numbers, we generated <italic>Roquin<sup>san/san</sup> Sap<sup>&#x02212;/&#x02212;</sup></italic> mice to determine whether numerically and functionally defective T<sub>FH</sub> cells in <italic>Roquin<sup>san/san</sup></italic> mice could abrogate the spontaneous GC reactions. As observed in SAP-deficient mice, loss of SAP in <italic>Roquin<sup>san/san</sup></italic> mice also had an effect on T<sub>FH</sub> cell numbers: there was a fourfold reduction (0.94 &#x000b1; 0.41% vs. 3.59 &#x000b1; 1.99%) in the percentage of T<sub>FH</sub> cells in <italic>Roquin<sup>san/san</sup> Sap<sup>&#x02212;/&#x02212;</sup></italic> mice relative to <italic>Roquin<sup>san/san</sup></italic> mice (P = 0.0056; <xref ref-type="fig" rid="fig3">Fig. 3 a</xref>, middle). SAP deficiency also resulted in a 10-fold reduction in the percentage of GC B cells in <italic>Roquin<sup>san/san</sup></italic> mice (4.27 &#x000b1; 1.93% vs. 0.43 &#x000b1; 0.23%; P = 0.0007; <xref ref-type="fig" rid="fig3">Fig. 3 b</xref>, middle). Immunohistochemistry paralleled the flow cytometry data, showing reduced size and number of GCs, and a reduction of T cell numbers within PNA-positive follicles (<xref ref-type="fig" rid="fig3">Fig. 3 c</xref>). These findings indicate that loss of SAP corrects the aberrant formation of T<sub>FH</sub> cells and the inappropriate GC reaction phenotype of <italic>Roquin<sup>san/san</sup></italic> to levels comparable to <italic>Roquin</italic><sup>+/+</sup> mice.</p><p>To test whether loss of SAP alters other T effector subsets in <italic>sanroque</italic> mice, we quantified Th1 and Th2 cells by flow cytometric staining for Tbet and Gata3, respectively. There were no statistically significant differences in the percentage of CD44<sup>high</sup>GATA3<sup>+</sup>CD4<sup>+</sup> cells (0.91 &#x000b1; 0.14% vs. 1.15 &#x000b1; 0.41%; P = 0.18) or CD44<sup>high</sup>Tbet<sup>+</sup>CD4<sup>+</sup> cells (6.76 &#x000b1; 10.6% vs. 8.66 &#x000b1; 5.74%; P = 0.59) between <italic>Roquin<sup>san/san</sup> Sap</italic><sup>+/+</sup> and <italic>Roquin<sup>san/san</sup> Sap<sup>&#x02212;/&#x02212;</sup></italic> mice in peripheral blood (<xref ref-type="fig" rid="fig4">Fig. 4, a and b</xref>). Lymph node CD44<sup>high</sup>GATA3<sup>+</sup>CD4<sup>+</sup> cells (2.11 &#x000b1; 1.68% vs. 1.59 &#x000b1; 0.81%; P = 0.54) and CD44<sup>high</sup>Tbet<sup>+</sup>CD4<sup>+</sup> cells (2.89 &#x000b1; 1.9% vs. 2.02 &#x000b1; 0.64%; P = 0.25) between <italic>Roquin<sup>san/san</sup> Sap</italic><sup>+/+</sup> and <italic>Roquin<sup>san/san</sup> Sap<sup>&#x02212;/&#x02212;</sup></italic> mice were slightly reduced, but these differences were not statistically significant (<xref ref-type="fig" rid="fig4">Fig. 4 c</xref>). In contrast, SAP deficiency caused an approximately fourfold reduction in <italic>Roquin<sup>san/san</sup></italic> lymph node T<sub>FH</sub> cells (3.93 &#x000b1; 0.47% vs. 1.11 &#x000b1; 0.38%; P = 0.001; <xref ref-type="fig" rid="fig4">Fig. 4 c</xref>). Collectively, these data indicate that T<sub>FH</sub> cells are the T helper subset whose generation is most severely impaired by SAP deficiency in <italic>Roquin<sup>san/san</sup></italic> mice.</p><fig id="fig4" position="float"><label>Figure 4.</label><caption><p><bold>Th1 and Th2 cells are present in <italic>Roquin<sup>san/san</sup></italic> mice in the absence of SAP and T<sub>FH</sub> cells, but not non-T<sub>FH</sub> effector cells, induce a GC response in wild-type mice.</bold> (a) Representative flow cytometric contour plots and (b) graphical analysis of GATA3<sup>+</sup>CD44<sup>high</sup>CD4<sup>+</sup> and Tbet<sup>+</sup>CD44<sup>high</sup>CD4<sup>+</sup> cells in mice of the indicated genotypes. Data are representative of two independent experiments (<italic>n</italic> &#x02265; 4 per group). (c) Representative dot plots of lymph node CD4<sup>+</sup>PD-1<sup>high</sup>CXCR5<sup>+</sup> (left), Tbet<sup>+</sup>CD44 <sup>high</sup>CD4<sup>+</sup> (middle), and GATA3<sup>+</sup>CD44<sup>high</sup>CD4<sup>+</sup> (right) cells. (d) Experimental outline for adoptive transfer of <italic>Roquin<sup>san/san</sup></italic> CD4<sup>+</sup> CD45.2 CD44<sup>high</sup> PD-1<sup>high</sup> CXCR5<sup>+</sup> or CD4<sup>+</sup> CD45.2 CD44<sup>high</sup> PD-1<sup>&#x02212;</sup> CXCR5<sup>&#x02212;</sup> T cells into CD45.1 C57BL/6 mice. (e) Flow cytometric contour plots and (f) dot plots of B220<sup>+</sup> GL-7<sup>+</sup> CD95<sup>+</sup> GC B cells from CD45.1 C57BL/6 recipients 3 wk after adoptive transfer of the indicated cell type. Data were generated from three mice per group (**, P &#x0003e; 0.001). In a, d, and e, the numbers in the plots represent percentages.</p></caption><graphic xlink:href="JEM_20081886_RGB_Fig4"/></fig></sec><sec><title>Transfer of <italic>Roquin<sup>san/san</sup></italic> T<sub>FH</sub> cells induces spontaneous GC reactions in wild-type mice</title><p>To test whether <italic>Roquin<sup>san/san</sup></italic> T<sub>FH</sub> cells are sufficient to induce GC reactions in unimmunized wild-type mice, CD45.2<sup>+</sup> PD-1<sup>high</sup> CXCR5<sup>+</sup> CD44<sup>high</sup> CD4<sup>+</sup> T<sub>FH</sub> cells or CD45.2<sup>+</sup> PD-1<sup>&#x02212;</sup> CXCR5<sup>&#x02212;</sup> CD44<sup>high</sup> CD4<sup>+</sup> non-T<sub>FH</sub> T effector cells were adoptively transferred into CD45.1<sup>+</sup> C57BL/6 mice. 3 wk after transfer, 8% of donor T<sub>FH</sub> cells retained their CXCR5<sup>high</sup> PD-1<sup>high</sup> phenotype. In mice receiving non-T<sub>FH</sub><italic>san/san</italic> CD44<sup>high</sup> effectors, &#x0223c;3% of the transferred cells had also acquired a comparable T<sub>FH</sub> phenotype (<xref ref-type="fig" rid="fig4">Fig. 4 d</xref>). Adoptive transfer of <italic>Roquin<sup>san/san</sup></italic> T<sub>FH</sub> cells resulted in a threefold increase in the number of GC B cells compared with control mice injected with PBS alone (P = 0.003; <xref ref-type="fig" rid="fig4">Fig. 4, e and f</xref>). A small increase in the percentage of GC cells was also observed in the mice that received non-T<sub>FH</sub> effector cells, although this was not statistically significant (<xref ref-type="fig" rid="fig4">Fig. 4, e and f</xref>). These data suggest that <italic>Roquin<sup>san/san</sup></italic> T<sub>FH</sub> cells can drive a GC reaction in the absence of exogenous antigen.</p></sec><sec><title>SAP deficiency abrogates the lupus-like phenotype of <italic>Roquin<sup>san/san</sup></italic> mice</title><p>Having established that SAP deficiency prevents T<sub>FH</sub> cell accumulation and selectively impairs GC responses, we sought to determine whether SAP deficiency affects the serum autoantibodies and renal pathology of <italic>Roquin<sup>san/san</sup></italic> mice. <italic>Roquin<sup>san/san</sup> Sap<sup>&#x02212;/&#x02212;</sup></italic> mice had not developed ANAs by 8 wk of age (<xref ref-type="fig" rid="fig5">Fig. 5 a</xref>). Assessment of high-affinity anti-dsDNA IgG antibodies at 6 mo of age (by immunofluorescence using <italic>Crithidia luciliae</italic> substrate) revealed positive dsDNA antibodies in all <italic>Roquin<sup>san/san</sup></italic> mice evaluated, whereas only one out of six <italic>Roquin<sup>san/san</sup> Sap<sup>&#x02212;/&#x02212;</sup></italic> mice had detectable antibodies. Renal histology revealed that <italic>Roquin<sup>san/san</sup> Sap<sup>&#x02212;/&#x02212;</sup></italic> mice had only minor interstitial nephritis and thickening of the mesangial matrix, with no detection of immune complex deposition observed by electron microscopy (<xref ref-type="fig" rid="fig5">Fig. 5, b and c</xref>). These data suggest that abrogation of signaling through SAP greatly reduced the autoimmune manifestations of <italic>Roquin<sup>san/san</sup></italic> mice. In contrast, SAP deficiency conferred no significant reduction of splenomegaly, lymphadenopathy, and hypergammaglobulinemia present in <italic>Roquin<sup>san/san</sup></italic> mice, indicating that these defects are not mediated by excessive T<sub>FH</sub> cell formation and GC function (Fig. S3, a&#x02013;c, available at <ext-link ext-link-type="uri" xlink:href="http://www.jem.org/cgi/content/full/jem.20081886/DC1">http://www.jem.org/cgi/content/full/jem.20081886/DC1</ext-link>).</p><fig id="fig5" position="float"><label>Figure 5.</label><caption><p><bold>Serum autoantibodies and renal pathology in <italic>Roquin<sup>san/san</sup> Sap<sup>&#x02212;/&#x02212;</sup></italic> mice and reduction of the GC response in SAP-deficient <italic>Roquin<sup>san/san</sup></italic> mice is caused by B cell&#x02013;extrinsic factors.</bold> (a, left) Representative staining of Hep-2 slides for detection of IgG ANA in the serum of 8-wk-old female <italic>Roquin<sup>san/san</sup></italic> and <italic>Roquin<sup>san/san</sup> Sap<sup>&#x02212;/&#x02212;</sup></italic> mice (<italic>n</italic> = 5 per group). (right) Detection of IgG anti-dsDNA serum antibodies in 6-mo-old female <italic>Roquin<sup>san/san</sup></italic> and <italic>Roquin<sup>san/san</sup> Sap<sup>&#x02212;/&#x02212;</sup></italic> mice determined by immunofluorescence staining using <italic>C. luciliae</italic> substrate. Data are representative of three independent experiments (<italic>n</italic> &#x02265; 5 per group). (b) Representative images of kidney sections stained with H&#x00026;E (top) or viewed under an electron microscope (bottom) from 6-mo-old female <italic>Roquin<sup>san/san</sup> Sap<sup>&#x02212;/&#x02212;</sup></italic> mice. <italic>Roquin<sup>san/san</sup> Sap<sup>&#x02212;/&#x02212;</sup></italic> mice show slight mesangial expansion on H&#x00026;E staining but no electron-dense deposits. Bars: (top) 100 &#x000b5;m; (bottom) 5 &#x000b5;m. (c) Score of nephritis severity in 6-mo-old female <italic>Roquin<sup>+/+</sup></italic>, <italic>Roquin<sup>san/san</sup></italic>, and <italic>Roquin<sup>san/san</sup> Sap<sup>&#x02212;/&#x02212;</sup></italic> mice as determined by histological analysis according to the criteria given in Table S1 (available at <ext-link ext-link-type="uri" xlink:href="http://www.jem.org/cgi/content/full/jem.20081886/DC1">http://www.jem.org/cgi/content/full/jem.20081886/DC1</ext-link>). Each symbol represents one mouse. Horizontal bars indicate medians. (d) Gating strategy for assessing the HEL-specific GC response (top) and graphic representation (bottom) of the total number of HEL-specific GC cells per spleen in mice with the indicated genotypes 7 d after cotransfer of SW<sub>HEL</sub> B cells and HEL<sup>2x</sup>-conjugated SRBCs. Data are representative of three independent experiments (<italic>n</italic> &#x02265; 4). Each symbol represents one mouse. (e) Gating strategy for determining HEL-specific extrafollicular plasma cells (top) and graphical representation (bottom) of the number of HEL-specific plasma cells 5 d after cotransfer into mice with the indicated genotypes. Data are representative of two independent experiments (<italic>n</italic> &#x02265; 3 per group). p-values are indicated on graphs.</p></caption><graphic xlink:href="JEM_20081886_RGB_Fig5"/></fig></sec><sec><title>Reduction of the GC response in <italic>Roquin<sup>san/san</sup> Sap<sup>&#x02212;/&#x02212;</sup></italic> mice is mainly caused by B cell&#x02013;extrinsic factors</title><p>Several studies have shown that SAP acts T cell intrinsically to regulate GC responses (<xref ref-type="bibr" rid="bib35">35</xref>, <xref ref-type="bibr" rid="bib37">37</xref>, <xref ref-type="bibr" rid="bib39">39</xref>), but some controversy still exists in the light of one study showing B cell&#x02013;intrinsic SAP-mediated effects (<xref ref-type="bibr" rid="bib40">40</xref>). To test whether the correction of the GC response observed in <italic>Roquin<sup>san/san</sup> Sap<sup>&#x02212;/&#x02212;</sup></italic> mice was caused by B cell&#x02013;extrinsic factors, we transferred SW<sub>HEL</sub> B cells expressing intact SAP into <italic>Roquin</italic><sup>+/+</sup>, <italic>Roquin<sup>san/san</sup></italic>, <italic>Sap<sup>&#x02212;/&#x02212;</sup></italic>, and <italic>Roquin<sup>san/san</sup> Sap<sup>&#x02212;/&#x02212;</sup></italic> mice, in conjunction with hen egg lysozyme (HEL)<sup>2x</sup>&#x02013;conjugated SRBCs.</p><p>Adoptively transferred SW<sub>HEL</sub> B cells formed HEL-specific GCs in all four cohorts. Significantly fewer GCs were observed in <italic>Sap<sup>&#x02212;/&#x02212;</sup></italic> than in wild-type mice (23,958 &#x000b1; 15,920 vs. 1,186 &#x000b1; 1,019; P = 0.005; <xref ref-type="fig" rid="fig5">Fig. 5 d</xref>), confirming a B cell&#x02013;extrinsic contribution of SAP to the GC response (<xref ref-type="bibr" rid="bib34">34</xref>, <xref ref-type="bibr" rid="bib36">36</xref>, <xref ref-type="bibr" rid="bib38">38</xref>). In addition, SAP deficiency corrected the extreme GC formation observed in <italic>Roquin<sup>san/san</sup></italic> mice (124,528 &#x000b1; 25,980 vs. 30,528 &#x000b1; 18,100; P = 0.0004) to a response of similar magnitude to <italic>Roquin</italic><sup>+/+</sup> mice (<xref ref-type="fig" rid="fig5">Fig. 5 a</xref>). This suggests that the SAP-mediated effect in <italic>Roquin<sup>san/san</sup></italic> mice is also caused by B cell&#x02013;extrinsic factors, and is most likely caused by SAP&#x02019;s regulation of T<sub>FH</sub> cells.</p><p>To determine whether the loss of <italic>Sap</italic> in <italic>Roquin<sup>san/san</sup></italic> mice selectively affected the GC response or also impaired the extrafollicular response, we identified donor-derived extrafollicular plasma cells containing intracellular anti-HEL Ig at day 5 after immunization (<xref ref-type="fig" rid="fig5">Fig. 5 e</xref>). At this time point, GC-derived plasma cells cannot be detected (<xref ref-type="bibr" rid="bib41">41</xref>). Although we observed a 4-fold decrease in SW<sub>HEL</sub> GC B cells, there was only a 1.3-fold decrease in the number of SW<sub>HEL</sub> extrafollicular plasma cells (53,198 &#x000b1; 1,528 vs. 40,528 &#x000b1; 7,548; P = 0.04) in <italic>Roquin<sup>san/san</sup> Sap<sup>&#x02212;/&#x02212;</sup></italic> recipients compared with <italic>Roquin<sup>san/san</sup> Sap</italic><sup>+/+</sup> controls (<xref ref-type="fig" rid="fig5">Fig. 5 e</xref>). These data suggest that the reduction of the GCs in <italic>Roquin<sup>san/san</sup></italic> mice caused by <italic>Sap</italic> deficiency is mainly a result of B cell&#x02013;extrinsic factors, and that this results in selective inhibition of the GC pathway.</p></sec><sec><title><italic>Roquin<sup>san/san</sup> Sap<sup>&#x02212;/&#x02212;</sup></italic> mice have reduced expression of ICOS and IL-21</title><p>We have demonstrated that <italic>Roquin<sup>san/san</sup> Sap<sup>&#x02212;/&#x02212;</sup></italic> mice have fewer T<sub>FH</sub> cells, a correction of the spontaneous GC response, and a reduction in autoimmune pathology. To gain insight into the possible functional T<sub>FH</sub> defect brought about by SAP deficiency in <italic>Roquin<sup>san/san</sup></italic> mice, we quantified the changes in the expression of ICOS and IL-21, both of which are increased in <italic>Roquin<sup>san/san</sup></italic> CD4<sup>+</sup> cells (<xref ref-type="bibr" rid="bib22">22</xref>) and are shown to be essential for T<sub>FH</sub> cell formation, homeostasis, and function (<xref ref-type="bibr" rid="bib33">33</xref>, <xref ref-type="bibr" rid="bib34">34</xref>, <xref ref-type="bibr" rid="bib42">42</xref>, <xref ref-type="bibr" rid="bib43">43</xref>). Loss of SAP reduced the levels of ICOS on both naive (CD44<sup>low</sup>) and activated/memory (CD44<sup>high</sup>) CD4<sup>+</sup> T cells in <italic>Roquin<sup>san/san</sup></italic> mice and to an even greater extent on <italic>Roquin</italic><sup>+/+</sup> mice (<xref ref-type="fig" rid="fig6">Fig. 6, a&#x02013;c</xref>). Despite this reduction, <italic>Roquin<sup>san/san</sup> Sap<sup>&#x02212;/&#x02212;</sup></italic> mice still expressed more than threefold higher levels of ICOS than <italic>Roquin</italic><sup>+/+</sup><italic>Sap</italic><sup>+/+</sup> mice.</p><fig id="fig6" position="float"><label>Figure 6.</label><caption><p><bold>T<sub>FH</sub> cell&#x02013;associated molecules are decreased in <italic>Roquin<sup>san/san</sup> Sap<sup>&#x02212;/&#x02212;</sup></italic> mice.</bold> (a) Representative flow cytometric histograms and (b and c) graphical analysis showing ICOS mean fluorescence intensity (MFI) of splenic naive CD44<sup>low</sup> (b) and activated/memory CD44<sup>high</sup> (c) CD4<sup>+</sup> T cells from 10-wk-old unimmunized mice of the indicated genotypes. Data are representative of three independent experiments. Each symbol represents one mouse. (d) ELISA quantification of IL-21 in supernatant from an overnight culture of splenocytes in the presence of PMA and ionomycin from mice of the indicated genotypes. Data are representative of three experiments. (e) Flow cytometric contour plots of CD40L expression on splenocytes, 5 h after stimulation with anti-CD3 and anti-CD28, derived from mice of the indicated genotypes. (left) Staining with an isotype control; (right) CD40L staining. (f) Histograms of the percentage of CD4<sup>+</sup> cells that express CD40L (gated as shown in e) 5 h after CD3 and CD28 stimulation on splenocytes from mice with the indicated genotypes. In d and f, error bars indicate means &#x000b1; SEM.</p></caption><graphic xlink:href="JEM_20081886_GS_Fig6"/></fig><p>To determine whether loss of SAP had an effect on the production of IL-21, which was increased in <italic>Roquin<sup>san/san</sup></italic> mice, we compared IL-21 production from <italic>Roquin</italic><sup>+/+</sup><italic>Sap</italic><sup>+/+</sup>, <italic>Roquin</italic><sup>+/+</sup><italic>Sap<sup>&#x02212;/&#x02212;</sup></italic>, <italic>Roquin<sup>san/san</sup> Sap</italic><sup>+/+</sup>, and <italic>Roquin<sup>san/san</sup> Sap<sup>&#x02212;/&#x02212;</sup></italic> splenocytes. SAP deficiency reduced IL-21 production by both <italic>Roquin<sup>san/san</sup></italic> and <italic>Roquin</italic><sup>+/+</sup> splenocytes (<xref ref-type="fig" rid="fig6">Fig. 6 d</xref>). Remarkably, the levels of IL-21 found in <italic>Roquin<sup>san/san</sup> Sap<sup>&#x02212;/&#x02212;</sup></italic> cultures were comparable to those of wild-type (<italic>Roquin</italic><sup>+/+</sup><italic>Sap</italic><sup>+/+</sup>) mice. As previously reported (<xref ref-type="bibr" rid="bib37">37</xref>), SAP deficiency resulted in higher CD40L expression upon activation in both <italic>Roquin</italic><sup>+/+</sup> and <italic>Roquin<sup>san/san</sup></italic> mice (<xref ref-type="fig" rid="fig6">Fig. 6, e and f</xref>).</p></sec><sec><title>IL-21 deficiency does not prevent autoimmunity in <italic>Roquin<sup>san/san</sup></italic> mice</title><p>Given that <italic>Roquin<sup>san/san</sup></italic> mice produce high levels of IL-21 and given the recently described role for IL-21 in T<sub>FH</sub> cell generation after immunization (<xref ref-type="bibr" rid="bib33">33</xref>, <xref ref-type="bibr" rid="bib34">34</xref>), we investigated whether IL-21 also controls autoantibody production, T<sub>FH</sub> cell accumulation, and spontaneous GC formation in these mice. To this end, we crossed <italic>Roquin<sup>san/san</sup></italic> mice to IL-21<sup>&#x02212;/&#x02212;</sup> mice on a C57BL/6 background and assessed ANA formation. There was no difference in the pattern or titer of ANAs produced by 10-wk-old <italic>Roquin<sup>san/san</sup> IL-21</italic><sup>+/+</sup> and <italic>Roquin<sup>san/san</sup> IL-21<sup>&#x02212;/&#x02212;</sup></italic> mice (<xref ref-type="fig" rid="fig7">Fig. 7, a and b</xref>). Overall, IL-21 deficiency did not affect the hypergammaglobulinemia of <italic>Roquin<sup>san/san</sup></italic> mice (<xref ref-type="fig" rid="fig7">Fig. 7 c</xref>), and consistent with previous reports (<xref ref-type="bibr" rid="bib44">44</xref>), IgG1 titers were reduced, whereas IgE titers were increased (<xref ref-type="fig" rid="fig7">Fig. 7 c</xref>). Likewise, loss of IL-21 did not correct the lymphadenopathy or the splenomegaly of <italic>Roquin<sup>san/san</sup></italic> mice (<xref ref-type="fig" rid="fig7">Fig. 7 d</xref>).</p><fig id="fig7" position="float"><label>Figure 7.</label><caption><p><bold>Lack of IL-21 does not affect the phenotype, T<sub>FH</sub> cell accumulation, or GC formation of <italic>Roquin<sup>san/san</sup></italic> mice.</bold> (a) IgG ANAs in the serum of mice of the genotypes indicated, detected by immunofluorescence using Hep-2 substrate. Data are representative of three independent experiments (<italic>n</italic> &#x02265; 5 mice per group). (b) Score of ANA staining intensity by confocal microscopy from sera taken from mice of the indicated genotypes. Data are representative of three independent experiments (<italic>n</italic> &#x02265; 5 mice per group). (c) Basal serum total IgG, IgG1, and IgE measured by ELISA. Data are representative of two independent experiments (<italic>n</italic> = 5 mice per group). (d) Lymph node and spleen weight in grams for mice of the indicated genotypes. Data are representative of two independent experiments (<italic>n</italic> &#x02265; 5 per group). (e) Flow cytometric contour plots and dot plots of PD-1<sup>high</sup>CXCR5<sup>+</sup>CD4<sup>+</sup> T<sub>FH</sub> cells and (f) GL-7<sup>+</sup>CD95<sup>+</sup>B220<sup>+</sup> GC cells from mice of the indicated genotypes. Data are representative of two independent experiments (<italic>n</italic> &#x02265; 5 mice per group). In e and f, the numbers in the plots represent percentages.</p></caption><graphic xlink:href="JEM_20081886_RGB_Fig7"/></fig><p>We then investigated whether IL-21 influences T<sub>FH</sub> cell accumulation and spontaneous GC formation. There was no difference in either the number of T<sub>FH</sub> cells or GC cells between <italic>Roquin<sup>san/san</sup> IL-21</italic><sup>+/+</sup> and <italic>Roquin<sup>san/san</sup> IL-21<sup>&#x02212;/&#x02212;</sup></italic> littermates, (<xref ref-type="fig" rid="fig7">Fig. 7, e and f</xref>). These data suggest that IL-21 does not play a role in spontaneous GC formation, T<sub>FH</sub> development, or accumulation in <italic>Roquin<sup>san/san</sup></italic> mice.</p></sec></sec><sec sec-type="discussion"><title>DISCUSSION</title><p>Elucidation of the defect that results in high-affinity antibodies to dsDNA is central to understanding lupus and, hence, the development of specific therapeutic interventions. In the <italic>Roquin<sup>san/san</sup></italic> model, a fundamental GC defect results in the production of autoantibodies. This pathway appears to be critical for disease development, because an impediment to GC formation conferred by halving the dose of <italic>Bcl6</italic> is sufficient to attenuate the lupus phenotype. Our data are consistent with other evidence that aberrant T cell help can cause spontaneous GC formation and autoimmunity (<xref ref-type="bibr" rid="bib9">9</xref>, <xref ref-type="bibr" rid="bib45">45</xref>). We show the expanded T<sub>FH</sub> cell subset, a consistent component of the <italic>Roquin<sup>san/san</sup></italic> phenotype, is responsible for excessive GC formation. In <italic>Roquin<sup>san/san</sup></italic> mice, GCs form in the absence of foreign antigen and yield ANAs. SAP deficiency reduces the size and activity of the T<sub>FH</sub> subset and abrogates autoantibody production and renal disease. These findings provide the in vivo cellular mechanism to link the defect in microRNA (miRNA)-mediated repression of T<sub>FH</sub> molecules conferred by the <italic>san</italic> allele of <italic>Roquin</italic> with the lupus phenotype of <italic>Roquin<sup>san/san</sup></italic> mice (<xref ref-type="bibr" rid="bib22">22</xref>, <xref ref-type="bibr" rid="bib28">28</xref>). Moreover, they elucidate a mechanism of lupus that could be generalized to other defects of T<sub>FH</sub> homeostasis. Importantly, they provide evidence that defects in positive selection of GC B cells can cause autoimmunity.</p><p>In this paper, we demonstrate that <italic>Roquin<sup>san/san</sup></italic> acts T cell intrinsically to drive an accumulation of T<sub>FH</sub> cells that support a spontaneous GC response. Overexpression of ICOS is a plausible mechanism, because ICOS is important for the generation and survival of T<sub>FH</sub> cells (<xref ref-type="bibr" rid="bib34">34</xref>, <xref ref-type="bibr" rid="bib42">42</xref>, <xref ref-type="bibr" rid="bib43">43</xref>), and Roquin normally acts to repress <italic>Icos</italic> miRNA (<xref ref-type="bibr" rid="bib28">28</xref>). Previously, we have shown that this accounts for the lymphoproliferation, splenomegaly, and lymphadenopathy of <italic>Roquin<sup>san/san</sup></italic> mice (<xref ref-type="bibr" rid="bib28">28</xref>). The data presented in this paper also show that CD28 signaling is a key contributor to the development of systemic autoimmunity in <italic>Roquin<sup>san/san</sup></italic> mice. CD28 is not only expressed on CD4<sup>+</sup> cells, but it has also been found to be expressed by stromal cells (<xref ref-type="bibr" rid="bib46">46</xref>) and plasma cells (<xref ref-type="bibr" rid="bib47">47</xref>), and this expression can influence B cell development and antibody responses. Nevertheless, our previous data showing that the increased plasma cell and GC numbers, and B cell activation in <italic>sanroque</italic> are predominantly B cell extrinsic (<xref ref-type="bibr" rid="bib22">22</xref>), together with the potent effects of SAP deficiency in the <italic>sanroque</italic> autoimmune phenotype, suggest that CD28 deficiency in T cells rather than in B cells or stromal cells is responsible for the observed effect. Thus, we infer that the <italic>sanroque</italic> lupus phenotype is T cell mediated. CD28 deficiency considerably decreased the abnormally high levels of ICOS normally found on <italic>Roquin<sup>san/san</sup></italic> T cells. This is likely to contribute to the abrogation of the lupus phenotype in a manner comparable to halving the gene dose of <italic>Icos</italic> (<xref ref-type="bibr" rid="bib28">28</xref>). A nonmutually exclusive explanation is that although ICOS overexpression causes a lymphoproliferative syndrome, danger signals may also be required for the production of autoantibodies that cause end-organ damage. This is because ligands for CD28 are dependent on Toll-like receptor ligation, which typically occurs during infections and tissue damage, and potentially after apoptosis. Because mice in this study were housed under specific pathogen-free conditions, one explanation for the source of the danger signal in the <italic>san/san</italic> model might be the abundance of apoptotic cells in GCs, which overloads the normal nonimmunogenic modes of disposal (<xref ref-type="bibr" rid="bib11">11</xref>). Apoptotic cells display self-antigens that are the target of the autoimmune response in lupus, and are ligands for TLR7 and/or TLR9 on antigen-presenting cells and/or B cells (<xref ref-type="bibr" rid="bib48">48</xref>).</p><p>Our data indicate that the GC is central to the autoimmune phenotype of <italic>Roquin<sup>san/san</sup></italic> mice, because reduction of spontaneous GCs, conferred by halving the gene dose of the transcriptional regulator <italic>Bcl6</italic>, results in a proportionate amelioration of autoimmune pathology. This heterozygote phenotype is a novel finding. Although previous reports describe intact antibody responses in <italic>Bcl6</italic><sup>+/&#x02212;</sup> mice on day 11 after immunization (<xref ref-type="bibr" rid="bib26">26</xref>), these are likely to derive predominantly from the extrafollicular response at this early time point. The heterozygote phenotype is consistent with the observation that GC differentiation is accompanied by only a twofold increase in <italic>Bcl6</italic> miRNA expression (<xref ref-type="bibr" rid="bib49">49</xref>). Although our work does not exclude an effect of halving the gene dose of <italic>Bcl6</italic> on T<sub>FH</sub> cell formation, it does strongly suggest that the GC reduction seen in <italic>Bcl6</italic><sup>+/&#x02212;</sup> mice is a consequence of reduced B cell&#x02013;expressed BCL6: in 50% <italic>Bcl6</italic><sup>+/+</sup>/50% <italic>Bcl6</italic><sup>+/&#x02212;</sup> mixed bone marrow chimeras, GC B cells were only decreased in GC B cells deriving from <italic>Bcl6</italic><sup>+/&#x02212;</sup> bone marrow. Furthermore, transfer of <italic>Bcl6</italic><sup>+/+</sup> SW<sub>HEL</sub> B cells into <italic>Bcl6</italic><sup>+/&#x02212;</sup> recipient mice, providing the major source of T<sub>FH</sub> cells, resulted in normal donor-derived GC numbers after HEL-SRBC immunization.</p><p>SAP deficiency abrogates autoimmunity in <italic>Roquin<sup>san/san</sup></italic> mice. SAP deficiency affects several T cell subsets and natural killer cells (<xref ref-type="bibr" rid="bib50">50</xref>, <xref ref-type="bibr" rid="bib51">51</xref>) but profoundly impairs the ability of T cells to provide help to B cells for GC formation (<xref ref-type="bibr" rid="bib37">37</xref>&#x02013;<xref ref-type="bibr" rid="bib39">39</xref>). Our results demonstrate that SAP deficiency specifically reduces the development of CD4<sup>+</sup> T cells with a T<sub>FH</sub> phenotype, leaving Th1 and Th2 cell formation largely intact. This, together with the evidence presented for the GC dependence of autoimmunity, as well as the observation that transfer of <italic>Roquin<sup>san/san</sup></italic> T<sub>FH</sub> cells induces spontaneous GC, places aberrant expansion of T<sub>FH</sub> cells at the root of spontaneous GC formation and autoimmunity in <italic>Roquin<sup>san/san</sup></italic> mice. This mechanism is consistent with another lupus model, B6.Sle1<italic><sup>yaa</sup></italic>, in which T cells have a transcriptional profile typical of T<sub>FH</sub> cells (<xref ref-type="bibr" rid="bib21">21</xref>).</p><p>SAP deficiency has been shown to ameliorate autoimmunity in another lupus-prone strain, MRL<italic><sup>lpr</sup></italic> mice (<xref ref-type="bibr" rid="bib52">52</xref>). These mice have been shown to also develop spontaneous GCs (<xref ref-type="bibr" rid="bib9">9</xref>), although SHM of autoreactive B blasts has been shown to occur in the T zone areas rather than within GCs (<xref ref-type="bibr" rid="bib16">16</xref>). SAP deficiency has been shown to eliminate the pathogenic CD4<sup>&#x02212;</sup>CD8<sup>&#x02212;</sup> T cells that account for the lymphadenopathy of MRL<italic><sup>lpr</sup></italic> mice (<xref ref-type="bibr" rid="bib52">52</xref>), and there is evidence that autoimmunity in MRL<italic><sup>lpr</sup></italic> mice is T cell dependent (<xref ref-type="bibr" rid="bib53">53</xref>). It will be interesting to examine whether dysregulated ectopically located T<sub>FH</sub> cells or an extrafollicular counterpart is contributing to autoimmunity in these mice. Finally, although <italic>sanroque</italic> SAP-deficient mice do not form spontaneous GCs, they still show hypergammaglobulinemia and very mild cell infiltrates in the kidney, suggesting that a non-T<sub>FH</sub>&#x02013;mediated pathway contributes to these manifestations in <italic>Roquin<sup>san/san</sup></italic> mice.</p><p>Our data add to previous studies demonstrating that SAP deficiency acts B cell extrinsically, causing a profound and selective impairment of GC reactions (<xref ref-type="bibr" rid="bib37">37</xref>) with little effect on extrafollicular plasma cell generation. The requirement for SAP for effective T<sub>FH</sub> cell function has previously been ascribed to dysregulated kinetics of ICOS up-regulation and increased expression of CD40L (<xref ref-type="bibr" rid="bib37">37</xref>), which we confirmed in the present study. Our work also shows that SAP signaling is required to maintain elevated baseline levels of ICOS in naive <italic>sanroque</italic> T cells.</p><p>An intriguing finding of this study was the lack of any role for IL-21 in <italic>Roquin<sup>san</sup></italic>-induced lupus, T<sub>FH</sub> cell accumulation, and spontaneous GC formation. Although recent reports have shown that IL-21 is involved in T<sub>FH</sub> cell generation and optimal GC responses (<xref ref-type="bibr" rid="bib33">33</xref>, <xref ref-type="bibr" rid="bib34">34</xref>), other groups have previously reported normal GC formation with an accumulation in IgG memory B cells in IL-21R<sup>&#x02212;/&#x02212;</sup> mice (<xref ref-type="bibr" rid="bib54">54</xref>). A recent paper has also shown that IL-21 can be produced by extrafollicular T cells, which contribute to autoimmunity in MRL<italic><sup>lpr</sup></italic> mice (<xref ref-type="bibr" rid="bib55">55</xref>). Furthermore, IL-21 has been shown to potently induce plasma cell generation from naive B cells (<xref ref-type="bibr" rid="bib56">56</xref>), suggesting an important role for IL-21 in extrafollicular B cell responses. Even if IL-21 turns out to be critical for GC B cell selection, it is possible that other molecules overexpressed by <italic>sanroque</italic> T<sub>FH</sub> cells, such as ICOS, substitute for the effects normally mediated by IL-21.</p><p>The pathway to systemic autoimmunity identified in this paper highlights the importance of negative selection of self-reactive lymphocytes in GCs. Autoreactive B cells are a normal component of the naive peripheral B cell repertoire. In lupus patients, these cells enter GCs, whereas in healthy individuals, they are excluded (<xref ref-type="bibr" rid="bib57">57</xref>). Other evidence indicates that in lupus, GCs can generate B cells that have antinuclear specificities from nonautoreactive precursors (<xref ref-type="bibr" rid="bib7">7</xref>). Furthermore, GCs are increased in lupus (<xref ref-type="bibr" rid="bib58">58</xref>). Regardless of their ontogeny, autoreactive centrocytes would normally fail to receive selection signals by T<sub>FH</sub> cells and would undergo apoptosis (<xref ref-type="bibr" rid="bib59">59</xref>). Our data suggest that this process is perturbed by the <italic>san</italic> allele of <italic>Roquin</italic>.</p><p>According to the prevailing model for T<sub>FH</sub> selection of centrocytes, large numbers of GC B cells compete with each other for the limiting available T cell help (<xref ref-type="bibr" rid="bib60">60</xref>) and for antigen on follicular dendritic cells. Centrocytes that have acquired higher affinity for antigen would scavenge more antigen from follicular dendritic cells, which would confer on them an avidity advantage in interactions with T<sub>FH</sub> cells compared with lower affinity B cells. Based on this model, we speculate that in <italic>Roquin<sup>san/san</sup></italic> mice, competition by B cells for T cell help is reduced by the expansion of T<sub>FH</sub> cells. Interactions between centrocytes and T<sub>FH</sub> cells are determined by affinity for MHC-peptide for the TCR modified by the action of accessory molecules. Loss of SAP in <italic>Roquin<sup>san/san</sup></italic> mice causes a reduction in ICOS overexpression, potentially increasing the antigen affinity required to reach the T<sub>FH</sub> activation threshold in <italic>Roquin<sup>san/san</sup> Sap<sup>&#x02212;/&#x02212;</sup></italic> mice.</p><p>Although the lupus phenotype of <italic>Roquin<sup>san/san</sup></italic> mice is Mendelian, apart from rare exceptions (<xref ref-type="bibr" rid="bib61">61</xref>), lupus is a polygenic disorder. Nevertheless, it is plausible that one or more polymorphisms or mutations that affect T<sub>FH</sub> homeostasis, such as those that regulate IL-21, ICOS, or ICOSL expression, could contribute to lupus pathogenesis. Because T<sub>FH</sub> cells are present in peripheral blood, this is a testable hypothesis. Indeed, there is evidence that SLE patients have increased numbers of circulating CD4<sup>+</sup>ICOS<sup>+</sup> cells in their peripheral blood compared with nonautoimmune individuals (<xref ref-type="bibr" rid="bib62">62</xref>). Because T<sub>FH</sub> cells are the cells expressing the highest levels of ICOS (<xref ref-type="bibr" rid="bib63">63</xref>, <xref ref-type="bibr" rid="bib64">64</xref>), it is possible that circulating CD4<sup>+</sup>ICOS<sup>+</sup> cells reflect an excessive T<sub>FH</sub> response, and is consistent with recent data showing that a subset of SLE patients have an increased proportion of CD4<sup>+</sup>CD45RO<sup>+</sup>CXCR5<sup>+</sup>ICOS<sup>high</sup>PD-1<sup>high</sup> cells in their peripheral blood (a phenotype that correlates with higher titers of anti-dsDNA antibodies and more severe kidney damage; unpublished data). If confirmed in independent studies, the GC&#x02013;T<sub>FH</sub> pathway elucidated in the <italic>Roquin<sup>san/san</sup></italic> model pathway would emerge as a novel and specific target for therapy.</p></sec><sec sec-type="materials|methods"><title>MATERIALS AND METHODS</title><sec><title/><sec><title>Mice and immunizations.</title><p><italic>Roquin<sup>san/san</sup></italic> and C57BL/6 (B6) mice, all crossed to <italic>Sap<sup>&#x02212;/&#x02212;</sup></italic>, <italic>Bcl6</italic><sup>+/&#x02212;</sup>, <italic>Cd28<sup>&#x02212;/&#x02212;</sup></italic>, and IL-21<sup>&#x02212;/&#x02212;</sup> mice, and SW<sub>HEL</sub> mice, were housed in specific pathogen-free conditions at the Australian National University Bioscience Facility. IL-21 KO mice were generated at Lexicon Pharmaceuticals, Inc. and were provided by M. Smyth (Peter MacCallum Cancer Centre, Melbourne, Australia) and ZymoGenetics, Inc. These mice were backcrossed 10 generations onto the C57BL/6 background. SW<sub>HEL</sub> mice carry a Vk10-&#x003ba; light chain transgene and a knocked in VH10 Ig heavy chain in place of the JH segments of the endogenous IgH gene that encode a high-affinity antibody for HEL (<xref ref-type="bibr" rid="bib65">65</xref>). All animal procedures were approved by the Australian National University Animal Ethics and Experimentation Committee.</p><p>To generate thymus-dependent responses where indicated in the figures, 8&#x02013;12-wk-old mice were immunized i.p. with 2 &#x000d7; 10<sup>9</sup> SRBCs (Institute of Medical and Veterinary Science Veterinary Services). For experiments involving SW<sub>HEL</sub> mice, 10<sup>4</sup> SW<sub>HEL</sub> B cells were transferred into recipients, which were simultaneously immunized i.v. with 2 &#x000d7; 10<sup>8</sup> SRBCs conjugated with mutant HEL<sup>2x</sup> using a protein conjugation kit (Invitrogen) (<xref ref-type="bibr" rid="bib41">41</xref>).</p></sec><sec><title>Bone marrow chimeras.</title><p>Recipient C57BL/6-Ly5a mice were sublethally irradiated with 1,000 Rad and were reconstituted via i.v. injection with 2 &#x000d7; 10<sup>6</sup> donor bone marrow&#x02013;derived hematopoetic stem cells.</p></sec><sec><title>Antibodies.</title><p>Antibodies and streptavidin conjugates for flow cytometry were from BD unless otherwise indicated: anti&#x02013;mouse B220-PerCP, CD4-PerCP, ICOS-PE (eBioscience), FoxP3 (eBioscience), GL-7&#x02013;FITC, GATA3-allophycocyanin, Tbet&#x02013;PerCP Cy5.5, CD95-PE, CXCR5-biotin, PD-1&#x02013;PE (eBioscience), CTLA-4&#x02013;PE, CD25-allophycocyanin, streptavidin&#x02013;PerCP Cy5.5, and CD40L-biotin. For immunohistochemistry, the primary antibodies and reagents used were rat anti&#x02013;mouse IgD (SouthernBiotech), biotinylated anti&#x02013;mouse TCR&#x003b2; (BD), rat anti&#x02013;mouse PD-1 (BioLegend), and PNA-biotin (Vector Laboratories); the secondary antibody used was rabbit anti&#x02013;rat horseradish peroxidase (HRP; Dako).</p></sec><sec><title>Cell isolation, culture, and stimulation.</title><p>Single-cell suspensions were prepared from spleens of unimmunized and/or immunized mice. Single-cell suspensions were prepared in RPMI 1640 medium (JRH Biosciences) supplemented with 2 mM <sc>l</sc>-Glutamine (Invitrogen), 100 U penicillin-streptomycin (Invitrogen), 0.1 mM nonessential amino acids (Invitrogen), 100 mM Hepes (Sigma-Aldrich), 5 &#x000d7; 10<sup>&#x02212;5</sup> 2-mercaptoethanol, and 10% fetal calf serum by sieving and gentle pipetting through 70-&#x000b5;m nylon mesh filters (Falcon; BD). Cells were then cultured for 24 h at 37&#x000b0;C/5% CO<sub>2</sub> with 50 ng/ml PMA (Sigma-Aldrich) and 1 &#x000b5;M ionomycin (Sigma-Aldrich) in triplicate wells. Cell culture supernatants were aspirated for further analysis by ELISA. For CD40L expression, cells were cultured in triplicate wells for 5 h in 96-well plates (Costar; Corning) with platebound 1 &#x000b5;g/ml anti-CD3 (BD) and 10 &#x000b5;g/ml anti-CD28 (BD). Biotinylated anti-CD40L antibody was added 2 h before harvesting.</p></sec><sec><title>Flow cytometry.</title><p>For surface staining, single-cell suspensions were prepared as described in the previous section, and cells were maintained in the dark at 4&#x000b0;C throughout. Cells were washed twice in ice-cold FACS buffer (2% fetal calf serum, 0.1% NaN<sub>3</sub> in PBS), and incubated with each antibody and conjugate layer for 30 min and washed thoroughly with FACS buffer between each layer. Intracellular staining was performed using the Cytofix/Cytoperm kit (BD) according to the manufacturer&#x02019;s instructions. For detection of HEL-binding B cells, HEL was conjugated to Alexa Fluor 647 using the manufacturer&#x02019;s instructions (Invitrogen). A FACSCalibur (BD) with CellQuest software (BD) was used for the acquisition of flow cytometric data, and FlowJo software (Tree Star, Inc.) was used for analysis.</p></sec><sec><title>Adoptive cell transfer experiments.</title><p>T<sub>FH</sub> cells (CD4<sup>+</sup>CD44<sup>high</sup>PD-1<sup>high</sup>CXCR5<sup>high</sup>) and non-T<sub>FH</sub> effector cells (CD4<sup>+</sup>CD44<sup>high</sup>PD-1<sup>int/lo</sup>CXCR5<sup>&#x02212;</sup>) from spleens and lymph nodes were prepared and stained as described in the previous paragraph and sorted on a FACSAria (BD). 5 &#x000d7; 10<sup>6</sup> sorted cells were resuspended in PBS and injected into the tail vein of unmanipulated CD45.1 C57BL/6 recipients. 3-wk after transfer, splenic donor (CD45.2) T<sub>FH</sub> cells and host GC cells were enumerated by flow cytometry.</p></sec><sec><title>ELISA.</title><p>Maxisorb plates (Thermo Fisher Scientific) were coated with 100 &#x000b5;g/ml of recombinant mouse IL-21R/Fc (R&#x00026;D Systems). Serial supernatant dilutions were applied in quadruplicate, and IL-21 concentration was determined with 200 ng/ml of HRP-conjugated goat anti&#x02013;mouse IL-21 IgG (R &#x00026; D systems). Bound IL-21 was detected using phosphatase substrate tablets (Sigma-Aldrich). Plates were read at 405 nm using a microplate reader (Thermomax; MDS Analytical Technologies). The titers for supernatant samples were calculated according to the standard curve generated using twofold dilutions of recombinant mouse IL-21 (500-15 pg/ml; R&#x00026;D Systems) and Prism software (GraphPad Software, Inc.). IL-17 ELISA was performed using the mouse IL-17A ELISA Ready-Set-Go! Kit (eBioscience) according to the manufacturer&#x02019;s instructions.</p><p>For analysis of total IgG, IgG1, and IgE titers, Maxisorb plates were coated with goat anti&#x02013;mouse &#x003ba; light chain or anti&#x02013;mouse IgE (BD). Serial serum dilutions were applied, and Ig concentration was determined with HRP-conjugated goat anti&#x02013;mouse IgG, IgG1 (SouthernBiotech), or biotinlyated IgE (BD), followed by streptavidin-HRP. The enzyme bound to plates was developed using phosphatase substrate tablets. Plates were read at 405 nm using a Thermomax microplate reader. The titers for serum samples were calculated as the log serum concentration required to achieve 50% maximum OD.</p></sec><sec><title>Immunohistochemistry.</title><p>5-&#x000b5;m acetone-fixed frozen sections of spleen were air dried and washed in 0.1 M Tris-buffered saline (TBS), pH 7.6, and were stained with various antibodies for 45 min at room temperature in a moist chamber. After a further wash in TBS, secondary reagents, previously absorbed in 10% normal mouse serum, were added to the sections for 45 min. Where biotin-conjugated primary or secondary reagents were used, streptavidin alkaline phosphatase (Vector Laboratories) was added after a further wash in TBS and incubated for 20 min. HRP activity was detected using diaminobenzidine tetrahydrochloride solution (Sigma-Aldrich) and hydrogen peroxide. Alkaline phosphatase activity was detected using the AP Substrate Kit III (Vector Laboratories). Sections were mounted with IMMU-MOUNT (Thermo Shandon) and viewed under a microscope (model IX71; Olympus).</p></sec><sec><title>Renal pathology.</title><p>Kidneys were fixed in 10% neutral buffered formalin. 4-&#x000b5;m paraffin-embedded sections were dewaxed and stained with hematoxylin and eosin (H&#x00026;E) and silver stains. For electron microscopy, kidneys were fixed in 2% glutaraldehyde in 0.1 M cacodylate buffer, pH 7.4, at room temperature overnight. They were then washed in 0.1 M cacodylate buffer, treated with 0.2 mm of filtered 2% osmium tetroxide in 0.1 M cacodylate buffer, pH 7.4, at room temperature for 2 h, and washed in double-distilled H<sub>2</sub>O. Samples were stained with 0.2 mm of filtered 2% aqueous uranyl acetate for 30 min at room temperature, dehydrated in ethanol, and embedded in 100% TAAB medium mix, low viscosity resin. They were then mounted in orientation silicone molds and heated in an oven at 70&#x000b0;C for 8&#x02013;12 h. The samples were examined on a transmission electron microscope (model 1011; JEOL) at 60 KeV. The images were captured using a digital camera (MegaView III) and the AnalySIS software package (Soft Imaging System; Olympus), and were subsequently scored using the criteria detailed in Table S1 (available at <ext-link ext-link-type="uri" xlink:href="http://www.jem.org/cgi/content/full/jem.20081886/DC1">http://www.jem.org/cgi/content/full/jem.20081886/DC1</ext-link>).</p></sec><sec><title>ANA and dsDNA assessment.</title><p>Serum obtained by eye bleed from 8-wk-old mice was diluted in PBS 1:40 and used for indirect immunofluorescence on fixed Hep-2 slides (Antibodies, Inc.) for ANA detection, and serum from 6-mo-old mice was diluted 1:20 and used for indirect immunofluorescence on fixed <italic>C. luciliae</italic> slides (Antibodies, Inc.) for ANA anti-dsDNA antibody detection, respectively. Alexa Fluor 488 goat anti&#x02013;mouse IgG (Invitrogen) was used to detect mouse antibodies. Autoantibodies were scored blind as negative or positive on a scale of 1&#x02013;3 based on the intensity of fluorescence. Relative levels of ANAs were estimated by viewing the slides using a confocal microscope (TCS SP5; Leica) at 20&#x000d7; magnification and a fixed laser power, and measuring the fluorescence of five randomly selected 1,250-&#x000b5;m<sup>2</sup> regions of Hep2 cells, compared with five regions where cells were absent. The sample-specific mean background was subtracted from the sample-specific mean fluorescence to give an estimation of fluorescent intensity. These results concurred with a blinded manual scoring of fluorescence for the same samples.</p></sec><sec><title>Statistical analysis.</title><p>Data were analyzed using a two-tailed Student&#x02019;s <italic>t</italic> test using Prism software.</p></sec><sec><title>Online supplemental material.</title><p>Fig. S1 illustrates that the loss of one allele of Bcl6 results in B cell&#x02013;intrinsic defects in GC formation. Fig. S2 a shows that CD4<sup>+</sup>FoxP3<sup>+</sup> T reg cells are expanded twofold in <italic>Roquin<sup>san/san</sup></italic> mice relative to <italic>Roquin</italic><sup>+/+</sup> mice. Fig. S2 b demonstrates that <italic>Roquin<sup>san/san</sup></italic> splenocytes produce equivalent levels of IL-17 to <italic>Roquin</italic><sup>+/+</sup> splenocytes. Fig. S3 (a and b) shows that <italic>Sap</italic> deficiency does not correct the splenomegaly and lymphadenopathy in <italic>Roquin<sup>san/san</sup></italic> mice. Fig. S3 c demonstrates that hyper-IgG in <italic>Roquin<sup>san/san</sup></italic> mice is not corrected in the absence of <italic>Sap</italic>. Table S1 describes the scoring strategy used to assess the severity of mouse nephritis. Online supplemental material is available at <ext-link ext-link-type="uri" xlink:href="http://www.jem.org/cgi/content/full/jem.20081886/DC1">http://www.jem.org/cgi/content/full/jem.20081886/DC1</ext-link>.</p></sec></sec></sec><sec sec-type="supplementary-material"><title>Supplementary Material</title><supplementary-material id="PMC_1" content-type="local-data"><caption><title>[Supplemental Material Index]</title></caption><media mimetype="text" mime-subtype="html" xlink:href="jem.20081886_index.html"/><media xlink:role="associated-file" mimetype="application" mime-subtype="pdf" xlink:href="jem.20081886_1.pdf"/></supplementary-material></sec></body><back><ack><p>We thank C. Goodnow for helpful discussions of this work, A. Prins for kidney sectioning, T. Chan for preparing HEL<sup>2X</sup>-conjugated SRBCs for SW<sub>HEL</sub> experiments, M. Townsend for cutting frozen spleen sections, and M. Smyth and ZymoGenetics, Inc. for providing us with the IL-21<sup>&#x02212;/&#x02212;</sup> mice.</p><p>This work was funded by a Viertel Senior Medical Research Fellowship and National Health and Medical Research Council grants 316956 and 427620 to C.G. Vinuesa.</p><p>The authors have no conflicting financial interests.</p></ack><ref-list><ref id="bib1"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hochberg</surname><given-names>M.C.</given-names></name></person-group><year>1997</year><article-title>Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus</article-title>.<source>Arthritis Rheum.</source><volume>40</volume>:<fpage>1725</fpage><pub-id pub-id-type="pmid">9324032</pub-id></mixed-citation></ref><ref id="bib2"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Arbuckle</surname><given-names>M.R.</given-names></name><name><surname>McClain</surname><given-names>M.T.</given-names></name><name><surname>Rubertone</surname><given-names>M.V.</given-names></name><name><surname>Scofield</surname><given-names>R.H.</given-names></name><name><surname>Dennis</surname><given-names>G.J.</given-names></name><name><surname>James</surname><given-names>J.A.</given-names></name><name><surname>Harley</surname><given-names>J.B.</given-names></name></person-group><year>2003</year><article-title>Development of autoantibodies before the clinical onset of systemic lupus erythematosus</article-title>.<source>N. Engl. J. Med.</source><volume>349</volume>:<fpage>1526</fpage>&#x02013;<lpage>1533</lpage><pub-id pub-id-type="pmid">14561795</pub-id></mixed-citation></ref><ref id="bib3"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rahman</surname><given-names>A.</given-names></name><name><surname>Isenberg</surname><given-names>D.A.</given-names></name></person-group><year>2008</year><article-title>Systemic lupus erythematosus</article-title>.<source>N. Engl. J. Med.</source><volume>358</volume>:<fpage>929</fpage>&#x02013;<lpage>939</lpage><pub-id pub-id-type="pmid">18305268</pub-id></mixed-citation></ref><ref id="bib4"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>MacLennan</surname><given-names>I.C.</given-names></name><name><surname>Toellner</surname><given-names>K.M.</given-names></name><name><surname>Cunningham</surname><given-names>A.F.</given-names></name><name><surname>Serre</surname><given-names>K.</given-names></name><name><surname>Sze</surname><given-names>D.M.</given-names></name><name><surname>Zuniga</surname><given-names>E.</given-names></name><name><surname>Cook</surname><given-names>M.C.</given-names></name><name><surname>Vinuesa</surname><given-names>C.G.</given-names></name></person-group><year>2003</year><article-title>Extrafollicular antibody responses</article-title>.<source>Immunol. Rev.</source><volume>194</volume>:<fpage>8</fpage>&#x02013;<lpage>18</lpage><pub-id pub-id-type="pmid">12846803</pub-id></mixed-citation></ref><ref id="bib5"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jacob</surname><given-names>J.</given-names></name><name><surname>Kelsoe</surname><given-names>G.</given-names></name><name><surname>Rajewsky</surname><given-names>K.</given-names></name><name><surname>Weiss</surname><given-names>U.</given-names></name></person-group><year>1991</year><article-title>Intraclonal generation of antibody mutants in germinal centers</article-title>.<source>Nature.</source><volume>354</volume>:<fpage>389</fpage>&#x02013;<lpage>392</lpage><pub-id pub-id-type="pmid">1956400</pub-id></mixed-citation></ref><ref id="bib6"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>MacLennan</surname><given-names>I.C.</given-names></name></person-group><year>1994</year><article-title>Germinal centers</article-title>.<source>Annu. Rev. Immunol.</source><volume>12</volume>:<fpage>117</fpage>&#x02013;<lpage>139</lpage><pub-id pub-id-type="pmid">8011279</pub-id></mixed-citation></ref><ref id="bib7"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Diamond</surname><given-names>B.</given-names></name><name><surname>Katz</surname><given-names>J.B.</given-names></name><name><surname>Paul</surname><given-names>E.</given-names></name><name><surname>Aranow</surname><given-names>C.</given-names></name><name><surname>Lustgarten</surname><given-names>D.</given-names></name><name><surname>Scharff</surname><given-names>M.D.</given-names></name></person-group><year>1992</year><article-title>The role of somatic mutation in the pathogenic anti-DNA response</article-title>.<source>Annu. Rev. Immunol.</source><volume>10</volume>:<fpage>731</fpage>&#x02013;<lpage>757</lpage><pub-id pub-id-type="pmid">1591002</pub-id></mixed-citation></ref><ref id="bib8"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Behar</surname><given-names>S.M.</given-names></name><name><surname>Lustgarten</surname><given-names>D.L.</given-names></name><name><surname>Corbet</surname><given-names>S.</given-names></name><name><surname>Scharff</surname><given-names>M.D.</given-names></name></person-group><year>1991</year><article-title>Characterization of somatically mutated S107 VH11-encoded anti-DNA autoantibodies derived from autoimmune (NZB &#x000d7; NZW)F1 mice</article-title>.<source>J. Exp. Med.</source><volume>173</volume>:<fpage>731</fpage>&#x02013;<lpage>741</lpage><pub-id pub-id-type="pmid">1900082</pub-id></mixed-citation></ref><ref id="bib9"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Luzina</surname><given-names>I.G.</given-names></name><name><surname>Atamas</surname><given-names>S.P.</given-names></name><name><surname>Storrer</surname><given-names>C.E.</given-names></name><name><surname>daSilva</surname><given-names>L.C.</given-names></name><name><surname>Kelsoe</surname><given-names>G.</given-names></name><name><surname>Papadimitriou</surname><given-names>J.C.</given-names></name><name><surname>Handwerger</surname><given-names>B.S.</given-names></name></person-group><year>2001</year><article-title>Spontaneous formation of germinal centers in autoimmune mice</article-title>.<source>J. Leukoc. Biol.</source><volume>70</volume>:<fpage>578</fpage>&#x02013;<lpage>584</lpage><pub-id pub-id-type="pmid">11590194</pub-id></mixed-citation></ref><ref id="bib10"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Casciola-Rosen</surname><given-names>L.A.</given-names></name><name><surname>Anhalt</surname><given-names>G.</given-names></name><name><surname>Rosen</surname><given-names>A.</given-names></name></person-group><year>1994</year><article-title>Autoantigens targeted in systemic lupus erythematosus are clustered in two populations of surface structures on apoptotic keratinocytes</article-title>.<source>J. Exp. Med.</source><volume>179</volume>:<fpage>1317</fpage>&#x02013;<lpage>1330</lpage><pub-id pub-id-type="pmid">7511686</pub-id></mixed-citation></ref><ref id="bib11"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hanayama</surname><given-names>R.</given-names></name><name><surname>Tanaka</surname><given-names>M.</given-names></name><name><surname>Miyasaka</surname><given-names>K.</given-names></name><name><surname>Aozasa</surname><given-names>K.</given-names></name><name><surname>Koike</surname><given-names>M.</given-names></name><name><surname>Uchiyama</surname><given-names>Y.</given-names></name><name><surname>Nagata</surname><given-names>S.</given-names></name></person-group><year>2004</year><article-title>Autoimmune disease and impaired uptake of apoptotic cells in MFG-E8-deficient mice</article-title>.<source>Science.</source><volume>304</volume>:<fpage>1147</fpage>&#x02013;<lpage>1150</lpage><pub-id pub-id-type="pmid">15155946</pub-id></mixed-citation></ref><ref id="bib12"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Weller</surname><given-names>S.</given-names></name><name><surname>Braun</surname><given-names>M.C.</given-names></name><name><surname>Tan</surname><given-names>B.K.</given-names></name><name><surname>Rosenwald</surname><given-names>A.</given-names></name><name><surname>Cordier</surname><given-names>C.</given-names></name><name><surname>Conley</surname><given-names>M.E.</given-names></name><name><surname>Plebani</surname><given-names>A.</given-names></name><name><surname>Kumararatne</surname><given-names>D.S.</given-names></name><name><surname>Bonnet</surname><given-names>D.</given-names></name><name><surname>Tournilhac</surname><given-names>O.</given-names></name><etal/></person-group><year>2004</year><article-title>Human blood IgM &#x0201c;memory&#x0201d; B cells are circulating splenic marginal zone B cells harboring a prediversified immunoglobulin repertoire</article-title>.<source>Blood.</source><volume>104</volume>:<fpage>3647</fpage>&#x02013;<lpage>3654</lpage><pub-id pub-id-type="pmid">15191950</pub-id></mixed-citation></ref><ref id="bib13"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kim</surname><given-names>J.H.</given-names></name><name><surname>Kim</surname><given-names>J.</given-names></name><name><surname>Jang</surname><given-names>Y.S.</given-names></name><name><surname>Chung</surname><given-names>G.H.</given-names></name></person-group><year>2006</year><article-title>Germinal center-independent affinity maturation in tumor necrosis factor receptor 1-deficient mice</article-title>.<source>J. Biochem. Mol. Biol.</source><volume>39</volume>:<fpage>586</fpage>&#x02013;<lpage>594</lpage><pub-id pub-id-type="pmid">17002880</pub-id></mixed-citation></ref><ref id="bib14"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shlomchik</surname><given-names>M.J.</given-names></name><name><surname>Aucoin</surname><given-names>A.H.</given-names></name><name><surname>Pisetsky</surname><given-names>D.S.</given-names></name><name><surname>Weigert</surname><given-names>M.G.</given-names></name></person-group><year>1987</year><article-title>Structure and function of anti-DNA autoantibodies derived from a single autoimmune mouse</article-title>.<source>Proc. Natl. Acad. Sci. USA.</source><volume>84</volume>:<fpage>9150</fpage>&#x02013;<lpage>9154</lpage><pub-id pub-id-type="pmid">3480535</pub-id></mixed-citation></ref><ref id="bib15"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shlomchik</surname><given-names>M.J.</given-names></name><name><surname>Marshak-Rothstein</surname><given-names>A.</given-names></name><name><surname>Wolfowicz</surname><given-names>C.B.</given-names></name><name><surname>Rothstein</surname><given-names>T.L.</given-names></name><name><surname>Weigert</surname><given-names>M.G.</given-names></name></person-group><year>1987</year><article-title>The role of clonal selection and somatic mutation in autoimmunity</article-title>.<source>Nature.</source><volume>328</volume>:<fpage>805</fpage>&#x02013;<lpage>811</lpage><pub-id pub-id-type="pmid">3498121</pub-id></mixed-citation></ref><ref id="bib16"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>William</surname><given-names>J.</given-names></name><name><surname>Euler</surname><given-names>C.</given-names></name><name><surname>Christensen</surname><given-names>S.</given-names></name><name><surname>Shlomchik</surname><given-names>M.J.</given-names></name></person-group><year>2002</year><article-title>Evolution of autoantibody responses via somatic hypermutation outside of germinal centers</article-title>.<source>Science.</source><volume>297</volume>:<fpage>2066</fpage>&#x02013;<lpage>2070</lpage><pub-id pub-id-type="pmid">12242446</pub-id></mixed-citation></ref><ref id="bib17"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Groom</surname><given-names>J.R.</given-names></name><name><surname>Fletcher</surname><given-names>C.A.</given-names></name><name><surname>Walters</surname><given-names>S.N.</given-names></name><name><surname>Grey</surname><given-names>S.T.</given-names></name><name><surname>Watt</surname><given-names>S.V.</given-names></name><name><surname>Sweet</surname><given-names>M.J.</given-names></name><name><surname>Smyth</surname><given-names>M.J.</given-names></name><name><surname>Mackay</surname><given-names>C.R.</given-names></name><name><surname>Mackay</surname><given-names>F.</given-names></name></person-group><year>2007</year><article-title>BAFF and MyD88 signals promote a lupuslike disease independent of T cells</article-title>.<source>J. Exp. Med.</source><volume>204</volume>:<fpage>1959</fpage>&#x02013;<lpage>1971</lpage><pub-id pub-id-type="pmid">17664289</pub-id></mixed-citation></ref><ref id="bib18"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yokoyama</surname><given-names>T.</given-names></name><name><surname>Tanahashi</surname><given-names>M.</given-names></name><name><surname>Kobayashi</surname><given-names>Y.</given-names></name><name><surname>Yamakawa</surname><given-names>Y.</given-names></name><name><surname>Maeda</surname><given-names>M.</given-names></name><name><surname>Inaba</surname><given-names>T.</given-names></name><name><surname>Kiriyama</surname><given-names>M.</given-names></name><name><surname>Fukai</surname><given-names>I.</given-names></name><name><surname>Fujii</surname><given-names>Y.</given-names></name></person-group><year>2002</year><article-title>The expression of Bcl-2 family proteins (Bcl-2, Bcl-x, Bax, Bak and Bim) in human lymphocytes</article-title>.<source>Immunol. Lett.</source><volume>81</volume>:<fpage>107</fpage>&#x02013;<lpage>113</lpage><pub-id pub-id-type="pmid">11852115</pub-id></mixed-citation></ref><ref id="bib19"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Liu</surname><given-names>Y.J.</given-names></name><name><surname>Joshua</surname><given-names>D.E.</given-names></name><name><surname>Williams</surname><given-names>G.T.</given-names></name><name><surname>Smith</surname><given-names>C.A.</given-names></name><name><surname>Gordon</surname><given-names>J.</given-names></name><name><surname>MacLennan</surname><given-names>I.C.</given-names></name></person-group><year>1989</year><article-title>Mechanism of antigen-driven selection in germinal centers</article-title>.<source>Nature.</source><volume>342</volume>:<fpage>929</fpage>&#x02013;<lpage>931</lpage><pub-id pub-id-type="pmid">2594086</pub-id></mixed-citation></ref><ref id="bib20"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Vinuesa</surname><given-names>C.G.</given-names></name><name><surname>Tangye</surname><given-names>S.G.</given-names></name><name><surname>Moser</surname><given-names>B.</given-names></name><name><surname>Mackay</surname><given-names>C.R.</given-names></name></person-group><year>2005</year><article-title>Follicular B helper T cells in antibody responses and autoimmunity</article-title>.<source>Nat. Rev. Immunol.</source><volume>5</volume>:<fpage>853</fpage>&#x02013;<lpage>865</lpage><pub-id pub-id-type="pmid">16261173</pub-id></mixed-citation></ref><ref id="bib21"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Subramanian</surname><given-names>S.</given-names></name><name><surname>Tus</surname><given-names>K.</given-names></name><name><surname>Li</surname><given-names>Q.Z.</given-names></name><name><surname>Wang</surname><given-names>A.</given-names></name><name><surname>Tian</surname><given-names>X.H.</given-names></name><name><surname>Zhou</surname><given-names>J.</given-names></name><name><surname>Liang</surname><given-names>C.</given-names></name><name><surname>Bartov</surname><given-names>G.</given-names></name><name><surname>McDaniel</surname><given-names>L.D.</given-names></name><name><surname>Zhou</surname><given-names>X.J.</given-names></name><etal/></person-group><year>2006</year><article-title>A Tlr7 translocation accelerates systemic autoimmunity in murine lupus</article-title>.<source>Proc. Natl. Acad. Sci. USA.</source><volume>103</volume>:<fpage>9970</fpage>&#x02013;<lpage>9975</lpage><pub-id pub-id-type="pmid">16777955</pub-id></mixed-citation></ref><ref id="bib22"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Vinuesa</surname><given-names>C.G.</given-names></name><name><surname>Cook</surname><given-names>M.C.</given-names></name><name><surname>Angelucci</surname><given-names>C.</given-names></name><name><surname>Athanasopoulos</surname><given-names>V.</given-names></name><name><surname>Rui</surname><given-names>L.</given-names></name><name><surname>Hill</surname><given-names>K.M.</given-names></name><name><surname>Yu</surname><given-names>D.</given-names></name><name><surname>Domaschenz</surname><given-names>H.</given-names></name><name><surname>Whittle</surname><given-names>B.</given-names></name><name><surname>Lambe</surname><given-names>T.</given-names></name><etal/></person-group><year>2005</year><article-title>A RING-type ubiquitin ligase family member required to repress follicular helper T cells and autoimmunity</article-title>.<source>Nature.</source><volume>435</volume>:<fpage>452</fpage>&#x02013;<lpage>458</lpage><pub-id pub-id-type="pmid">15917799</pub-id></mixed-citation></ref><ref id="bib23"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hsu</surname><given-names>H.C.</given-names></name><name><surname>Yang</surname><given-names>P.</given-names></name><name><surname>Wang</surname><given-names>J.</given-names></name><name><surname>Wu</surname><given-names>Q.</given-names></name><name><surname>Myers</surname><given-names>R.</given-names></name><name><surname>Chen</surname><given-names>J.</given-names></name><name><surname>Yi</surname><given-names>J.</given-names></name><name><surname>Guentert</surname><given-names>T.</given-names></name><name><surname>Tousson</surname><given-names>A.</given-names></name><name><surname>Stanus</surname><given-names>A.L.</given-names></name><etal/></person-group><year>2008</year><article-title>Interleukin 17-producing T helper cells and interleukin 17 orchestrate autoreactive germinal center development in autoimmune BXD2 mice</article-title>.<source>Nat. Immunol.</source><volume>9</volume>:<fpage>166</fpage>&#x02013;<lpage>175</lpage><pub-id pub-id-type="pmid">18157131</pub-id></mixed-citation></ref><ref id="bib24"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Vinuesa</surname><given-names>C.G.</given-names></name><name><surname>Goodnow</surname><given-names>C.C.</given-names></name></person-group><year>2004</year><article-title>Illuminating autoimmune regulators through controlled variation of the mouse genome sequence</article-title>.<source>Immunity.</source><volume>20</volume>:<fpage>669</fpage>&#x02013;<lpage>679</lpage><pub-id pub-id-type="pmid">15189733</pub-id></mixed-citation></ref><ref id="bib25"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dent</surname><given-names>A.L.</given-names></name><name><surname>Shaffer</surname><given-names>A.L.</given-names></name><name><surname>Yu</surname><given-names>X.</given-names></name><name><surname>Allman</surname><given-names>D.</given-names></name><name><surname>Staudt</surname><given-names>L.M.</given-names></name></person-group><year>1997</year><article-title>Control of inflammation, cytokine expression, and germinal center formation by BCL-6</article-title>.<source>Science.</source><volume>276</volume>:<fpage>589</fpage>&#x02013;<lpage>592</lpage><pub-id pub-id-type="pmid">9110977</pub-id></mixed-citation></ref><ref id="bib26"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ye</surname><given-names>B.H.</given-names></name><name><surname>Cattoretti</surname><given-names>G.</given-names></name><name><surname>Shen</surname><given-names>Q.</given-names></name><name><surname>Zhang</surname><given-names>J.</given-names></name><name><surname>Hawe</surname><given-names>N.</given-names></name><name><surname>de Waard</surname><given-names>R.</given-names></name><name><surname>Leung</surname><given-names>C.</given-names></name><name><surname>Nouri-Shirazi</surname><given-names>M.</given-names></name><name><surname>Orazi</surname><given-names>A.</given-names></name><name><surname>Chaganti</surname><given-names>R.S.</given-names></name><etal/></person-group><year>1997</year><article-title>The BCL-6 proto-oncogene controls germinal-center formation and Th2-type inflammation</article-title>.<source>Nat. Genet.</source><volume>16</volume>:<fpage>161</fpage>&#x02013;<lpage>170</lpage><pub-id pub-id-type="pmid">9171827</pub-id></mixed-citation></ref><ref id="bib27"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shaffer</surname><given-names>A.L.</given-names></name><name><surname>Yu</surname><given-names>X.</given-names></name><name><surname>He</surname><given-names>Y.</given-names></name><name><surname>Boldrick</surname><given-names>J.</given-names></name><name><surname>Chan</surname><given-names>E.P.</given-names></name><name><surname>Staudt</surname><given-names>L.M.</given-names></name></person-group><year>2000</year><article-title>BCL-6 represses genes that function in lymphocyte differentiation, inflammation, and cell cycle control</article-title>.<source>Immunity.</source><volume>13</volume>:<fpage>199</fpage>&#x02013;<lpage>212</lpage><pub-id pub-id-type="pmid">10981963</pub-id></mixed-citation></ref><ref id="bib28"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yu</surname><given-names>D.</given-names></name><name><surname>Tan</surname><given-names>A.H.</given-names></name><name><surname>Hu</surname><given-names>X.</given-names></name><name><surname>Athanasopoulos</surname><given-names>V.</given-names></name><name><surname>Simpson</surname><given-names>N.</given-names></name><name><surname>Silva</surname><given-names>D.G.</given-names></name><name><surname>Hutloff</surname><given-names>A.</given-names></name><name><surname>Giles</surname><given-names>K.M.</given-names></name><name><surname>Leedman</surname><given-names>P.J.</given-names></name><name><surname>Lam</surname><given-names>K.P.</given-names></name><etal/></person-group><year>2007</year><article-title>Roquin represses autoimmunity by limiting inducible T-cell co-stimulator messenger RNA</article-title>.<source>Nature.</source><volume>450</volume>:<fpage>299</fpage>&#x02013;<lpage>303</lpage><pub-id pub-id-type="pmid">18172933</pub-id></mixed-citation></ref><ref id="bib29"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Linterman</surname><given-names>M.A.</given-names></name><name><surname>Rigby</surname><given-names>R.J.</given-names></name><name><surname>Wong</surname><given-names>R.</given-names></name><name><surname>Silva</surname><given-names>D.</given-names></name><name><surname>Withers</surname><given-names>D.</given-names></name><name><surname>Anderson</surname><given-names>G.</given-names></name><name><surname>Verma</surname><given-names>N.K.</given-names></name><name><surname>Brink</surname><given-names>R.</given-names></name><name><surname>Hutloff</surname><given-names>A.</given-names></name><name><surname>Goodnow</surname><given-names>C.C.</given-names></name><name><surname>Vinuesa</surname><given-names>C.G.</given-names></name></person-group><year>2009</year><article-title>Roquin differentiates the specialized functions of duplicated T cell co-stimulatory receptor genes <italic>Cd28</italic> and <italic>Icos</italic></article-title>.<source>Immunity.</source><comment>In press</comment></mixed-citation></ref><ref id="bib30"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Haynes</surname><given-names>N.M.</given-names></name><name><surname>Allen</surname><given-names>C.D.</given-names></name><name><surname>Lesley</surname><given-names>R.</given-names></name><name><surname>Ansel</surname><given-names>K.M.</given-names></name><name><surname>Killeen</surname><given-names>N.</given-names></name><name><surname>Cyster</surname><given-names>J.G.</given-names></name></person-group><year>2007</year><article-title>Role of CXCR5 and CCR7 in follicular Th cell positioning and appearance of a programmed cell death gene-1high germinal center-associated subpopulation</article-title>.<source>J. Immunol.</source><volume>179</volume>:<fpage>5099</fpage>&#x02013;<lpage>5108</lpage><pub-id pub-id-type="pmid">17911595</pub-id></mixed-citation></ref><ref id="bib31"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Seo</surname><given-names>S.J.</given-names></name><name><surname>Fields</surname><given-names>M.L.</given-names></name><name><surname>Buckler</surname><given-names>J.L.</given-names></name><name><surname>Reed</surname><given-names>A.J.</given-names></name><name><surname>Mandik-Nayak</surname><given-names>L.</given-names></name><name><surname>Nish</surname><given-names>S.A.</given-names></name><name><surname>Noelle</surname><given-names>R.J.</given-names></name><name><surname>Turka</surname><given-names>L.A.</given-names></name><name><surname>Finkelman</surname><given-names>F.D.</given-names></name><name><surname>Caton</surname><given-names>A.J.</given-names></name><name><surname>Erikson</surname><given-names>J.</given-names></name></person-group><year>2002</year><article-title>The impact of T helper and T regulatory cells on the regulation of anti-double-stranded DNA B cells</article-title>.<source>Immunity.</source><volume>16</volume>:<fpage>535</fpage>&#x02013;<lpage>546</lpage><pub-id pub-id-type="pmid">11970877</pub-id></mixed-citation></ref><ref id="bib32"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Stockinger</surname><given-names>B.</given-names></name><name><surname>Veldhoen</surname><given-names>M.</given-names></name></person-group><year>2007</year><article-title>Differentiation and function of Th17 T cells</article-title>.<source>Curr. Opin. Immunol.</source><volume>19</volume>:<fpage>281</fpage>&#x02013;<lpage>286</lpage><pub-id pub-id-type="pmid">17433650</pub-id></mixed-citation></ref><ref id="bib33"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Vogelzang</surname><given-names>A.</given-names></name><name><surname>McGuire</surname><given-names>H.M.</given-names></name><name><surname>Yu</surname><given-names>D.</given-names></name><name><surname>Sprent</surname><given-names>J.</given-names></name><name><surname>Mackay</surname><given-names>C.R.</given-names></name><name><surname>King</surname><given-names>C.</given-names></name></person-group><year>2008</year><article-title>A fundamental role for interleukin-21 in the generation of T follicular helper cells</article-title>.<source>Immunity.</source><volume>29</volume>:<fpage>127</fpage>&#x02013;<lpage>137</lpage><pub-id pub-id-type="pmid">18602282</pub-id></mixed-citation></ref><ref id="bib34"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nurieva</surname><given-names>R.I.</given-names></name><name><surname>Chung</surname><given-names>Y.</given-names></name><name><surname>Hwang</surname><given-names>D.</given-names></name><name><surname>Yang</surname><given-names>X.O.</given-names></name><name><surname>Kang</surname><given-names>H.S.</given-names></name><name><surname>Ma</surname><given-names>L.</given-names></name><name><surname>Wang</surname><given-names>Y.H.</given-names></name><name><surname>Watowich</surname><given-names>S.S.</given-names></name><name><surname>Jetten</surname><given-names>A.M.</given-names></name><name><surname>Tian</surname><given-names>Q.</given-names></name><name><surname>Dong</surname><given-names>C.</given-names></name></person-group><year>2008</year><article-title>Generation of T follicular helper cells is mediated by interleukin-21 but independent of T helper 1, 2, or 17 cell lineages</article-title>.<source>Immunity.</source><volume>29</volume>:<fpage>138</fpage>&#x02013;<lpage>149</lpage><pub-id pub-id-type="pmid">18599325</pub-id></mixed-citation></ref><ref id="bib35"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Crotty</surname><given-names>S.</given-names></name><name><surname>Kersh</surname><given-names>E.N.</given-names></name><name><surname>Cannons</surname><given-names>J.</given-names></name><name><surname>Schwartzberg</surname><given-names>P.L.</given-names></name><name><surname>Ahmed</surname><given-names>R.</given-names></name></person-group><year>2003</year><article-title>SAP is required for generating long-term humoral immunity</article-title>.<source>Nature.</source><volume>421</volume>:<fpage>282</fpage>&#x02013;<lpage>287</lpage><pub-id pub-id-type="pmid">12529646</pub-id></mixed-citation></ref><ref id="bib36"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hron</surname><given-names>J.D.</given-names></name><name><surname>Caplan</surname><given-names>L.</given-names></name><name><surname>Gerth</surname><given-names>A.J.</given-names></name><name><surname>Schwartzberg</surname><given-names>P.L.</given-names></name><name><surname>Peng</surname><given-names>S.L.</given-names></name></person-group><year>2004</year><article-title>SH2D1A regulates T-dependent humoral autoimmunity</article-title>.<source>J. Exp. Med.</source><volume>200</volume>:<fpage>261</fpage>&#x02013;<lpage>266</lpage><pub-id pub-id-type="pmid">15263031</pub-id></mixed-citation></ref><ref id="bib37"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cannons</surname><given-names>J.L.</given-names></name><name><surname>Yu</surname><given-names>L.J.</given-names></name><name><surname>Jankovic</surname><given-names>D.</given-names></name><name><surname>Crotty</surname><given-names>S.</given-names></name><name><surname>Horai</surname><given-names>R.</given-names></name><name><surname>Kirby</surname><given-names>M.</given-names></name><name><surname>Anderson</surname><given-names>S.</given-names></name><name><surname>Cheever</surname><given-names>A.W.</given-names></name><name><surname>Sher</surname><given-names>A.</given-names></name><name><surname>Schwartzberg</surname><given-names>P.L.</given-names></name></person-group><year>2006</year><article-title>SAP regulates T cell&#x02013;mediated help for humoral immunity by a mechanism distinct from cytokine regulation</article-title>.<source>J. Exp. Med.</source><volume>203</volume>:<fpage>1551</fpage>&#x02013;<lpage>1565</lpage><pub-id pub-id-type="pmid">16754717</pub-id></mixed-citation></ref><ref id="bib38"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>McCausland</surname><given-names>M.M.</given-names></name><name><surname>Yusuf</surname><given-names>I.</given-names></name><name><surname>Tran</surname><given-names>H.</given-names></name><name><surname>Ono</surname><given-names>N.</given-names></name><name><surname>Yanagi</surname><given-names>Y.</given-names></name><name><surname>Crotty</surname><given-names>S.</given-names></name></person-group><year>2007</year><article-title>SAP regulation of follicular helper CD4 T cell development and humoral immunity is independent of SLAM and Fyn kinase</article-title>.<source>J. Immunol.</source><volume>178</volume>:<fpage>817</fpage>&#x02013;<lpage>828</lpage><pub-id pub-id-type="pmid">17202343</pub-id></mixed-citation></ref><ref id="bib39"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Veillette</surname><given-names>A.</given-names></name><name><surname>Zhang</surname><given-names>S.</given-names></name><name><surname>Shi</surname><given-names>X.</given-names></name><name><surname>Dong</surname><given-names>Z.</given-names></name><name><surname>Davidson</surname><given-names>D.</given-names></name><name><surname>Zhong</surname><given-names>M.C.</given-names></name></person-group><year>2008</year><article-title>SAP expression in T cells, not in B cells, is required for humoral immunity</article-title>.<source>Proc. Natl. Acad. Sci. USA.</source><volume>105</volume>:<fpage>1273</fpage>&#x02013;<lpage>1278</lpage><pub-id pub-id-type="pmid">18212118</pub-id></mixed-citation></ref><ref id="bib40"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Morra</surname><given-names>M.</given-names></name><name><surname>Barrington</surname><given-names>R.A.</given-names></name><name><surname>Abadia-Molina</surname><given-names>A.C.</given-names></name><name><surname>Okamoto</surname><given-names>S.</given-names></name><name><surname>Julien</surname><given-names>A.</given-names></name><name><surname>Gullo</surname><given-names>C.</given-names></name><name><surname>Kalsy</surname><given-names>A.</given-names></name><name><surname>Edwards</surname><given-names>M.J.</given-names></name><name><surname>Chen</surname><given-names>G.</given-names></name><name><surname>Spolski</surname><given-names>R.</given-names></name><etal/></person-group><year>2005</year><article-title>Defective B cell responses in the absence of SH2D1A</article-title>.<source>Proc. Natl. Acad. Sci. USA.</source><volume>102</volume>:<fpage>4819</fpage>&#x02013;<lpage>4823</lpage><pub-id pub-id-type="pmid">15774582</pub-id></mixed-citation></ref><ref id="bib41"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Paus</surname><given-names>D.</given-names></name><name><surname>Phan</surname><given-names>T.G.</given-names></name><name><surname>Chan</surname><given-names>T.D.</given-names></name><name><surname>Gardam</surname><given-names>S.</given-names></name><name><surname>Basten</surname><given-names>A.</given-names></name><name><surname>Brink</surname><given-names>R.</given-names></name></person-group><year>2006</year><article-title>Antigen recognition strength regulates the choice between extrafollicular plasma cell and germinal center B cell differentiation</article-title>.<source>J. Exp. Med.</source><volume>203</volume>:<fpage>1081</fpage>&#x02013;<lpage>1091</lpage><pub-id pub-id-type="pmid">16606676</pub-id></mixed-citation></ref><ref id="bib42"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bossaller</surname><given-names>L.</given-names></name><name><surname>Burger</surname><given-names>J.</given-names></name><name><surname>Draeger</surname><given-names>R.</given-names></name><name><surname>Grimbacher</surname><given-names>B.</given-names></name><name><surname>Knoth</surname><given-names>R.</given-names></name><name><surname>Plebani</surname><given-names>A.</given-names></name><name><surname>Durandy</surname><given-names>A.</given-names></name><name><surname>Baumann</surname><given-names>U.</given-names></name><name><surname>Schlesier</surname><given-names>M.</given-names></name><name><surname>Welcher</surname><given-names>A.A.</given-names></name><etal/></person-group><year>2006</year><article-title>ICOS deficiency is associated with a severe reduction of CXCR5+CD4 germinal center Th cells</article-title>.<source>J. Immunol.</source><volume>177</volume>:<fpage>4927</fpage>&#x02013;<lpage>4932</lpage><pub-id pub-id-type="pmid">16982935</pub-id></mixed-citation></ref><ref id="bib43"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Akiba</surname><given-names>H.</given-names></name><name><surname>Takeda</surname><given-names>K.</given-names></name><name><surname>Kojima</surname><given-names>Y.</given-names></name><name><surname>Usui</surname><given-names>Y.</given-names></name><name><surname>Harada</surname><given-names>N.</given-names></name><name><surname>Yamazaki</surname><given-names>T.</given-names></name><name><surname>Ma</surname><given-names>J.</given-names></name><name><surname>Tezuka</surname><given-names>K.</given-names></name><name><surname>Yagita</surname><given-names>H.</given-names></name><name><surname>Okumura</surname><given-names>K.</given-names></name></person-group><year>2005</year><article-title>The role of ICOS in the CXCR5+ follicular B helper T cell maintenance in vivo</article-title>.<source>J. Immunol.</source><volume>175</volume>:<fpage>2340</fpage>&#x02013;<lpage>2348</lpage><pub-id pub-id-type="pmid">16081804</pub-id></mixed-citation></ref><ref id="bib44"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ozaki</surname><given-names>K.</given-names></name><name><surname>Spolski</surname><given-names>R.</given-names></name><name><surname>Feng</surname><given-names>C.G.</given-names></name><name><surname>Qi</surname><given-names>C.F.</given-names></name><name><surname>Cheng</surname><given-names>J.</given-names></name><name><surname>Sher</surname><given-names>A.</given-names></name><name><surname>Morse</surname><given-names>H.C.</given-names><suffix>3rd</suffix></name><name><surname>Liu</surname><given-names>C.</given-names></name><name><surname>Schwartzberg</surname><given-names>P.L.</given-names></name><name><surname>Leonard</surname><given-names>W.J.</given-names></name></person-group><year>2002</year><article-title>A critical role for IL-21 in regulating immunoglobulin production</article-title>.<source>Science.</source><volume>298</volume>:<fpage>1630</fpage>&#x02013;<lpage>1634</lpage><pub-id pub-id-type="pmid">12446913</pub-id></mixed-citation></ref><ref id="bib45"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Munthe</surname><given-names>L.A.</given-names></name><name><surname>Corthay</surname><given-names>A.</given-names></name><name><surname>Os</surname><given-names>A.</given-names></name><name><surname>Zangani</surname><given-names>M.</given-names></name><name><surname>Bogen</surname><given-names>B.</given-names></name></person-group><year>2005</year><article-title>Systemic autoimmune disease caused by autoreactive B cells that receive chronic help from Ig V region-specific T cells</article-title>.<source>J. Immunol.</source><volume>175</volume>:<fpage>2391</fpage>&#x02013;<lpage>2400</lpage><pub-id pub-id-type="pmid">16081810</pub-id></mixed-citation></ref><ref id="bib46"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gray Parkin</surname><given-names>K.</given-names></name><name><surname>Stephan</surname><given-names>R.P.</given-names></name><name><surname>Apilado</surname><given-names>R.G.</given-names></name><name><surname>Lill-Elghanian</surname><given-names>D.A.</given-names></name><name><surname>Lee</surname><given-names>K.P.</given-names></name><name><surname>Saha</surname><given-names>B.</given-names></name><name><surname>Witte</surname><given-names>P.L.</given-names></name></person-group><year>2002</year><article-title>Expression of CD28 by bone marrow stromal cells and its involvement in B lymphopoiesis</article-title>.<source>J. Immunol.</source><volume>169</volume>:<fpage>2292</fpage>&#x02013;<lpage>2302</lpage><pub-id pub-id-type="pmid">12193694</pub-id></mixed-citation></ref><ref id="bib47"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Delogu</surname><given-names>A.</given-names></name><name><surname>Schebesta</surname><given-names>A.</given-names></name><name><surname>Sun</surname><given-names>Q.</given-names></name><name><surname>Aschenbrenner</surname><given-names>K.</given-names></name><name><surname>Perlot</surname><given-names>T.</given-names></name><name><surname>Busslinger</surname><given-names>M.</given-names></name></person-group><year>2006</year><article-title>Gene repression by Pax5 in B cells is essential for blood cell homeostasis and is reversed in plasma cells</article-title>.<source>Immunity.</source><volume>24</volume>:<fpage>269</fpage>&#x02013;<lpage>281</lpage><pub-id pub-id-type="pmid">16546096</pub-id></mixed-citation></ref><ref id="bib48"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Krieg</surname><given-names>A.M.</given-names></name><name><surname>Vollmer</surname><given-names>J.</given-names></name></person-group><year>2007</year><article-title>Toll-like receptors 7, 8, and 9: linking innate immunity to autoimmunity</article-title>.<source>Immunol. Rev.</source><volume>220</volume>:<fpage>251</fpage>&#x02013;<lpage>269</lpage><pub-id pub-id-type="pmid">17979852</pub-id></mixed-citation></ref><ref id="bib49"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Vinuesa</surname><given-names>C.G.</given-names></name><name><surname>Cook</surname><given-names>M.C.</given-names></name><name><surname>Cooke</surname><given-names>M.P.</given-names></name><name><surname>Maclennan</surname><given-names>I.C.</given-names></name><name><surname>Goodnow</surname><given-names>C.C.</given-names></name></person-group><year>2002</year><article-title>Analysis of B cell memory formation using DNA microarrays</article-title>.<source>Ann. NY Acad. Sci.</source><volume>975</volume>:<fpage>33</fpage>&#x02013;<lpage>45</lpage><pub-id pub-id-type="pmid">12538152</pub-id></mixed-citation></ref><ref id="bib50"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Griewank</surname><given-names>K.</given-names></name><name><surname>Borowski</surname><given-names>C.</given-names></name><name><surname>Rietdijk</surname><given-names>S.</given-names></name><name><surname>Wang</surname><given-names>N.</given-names></name><name><surname>Julien</surname><given-names>A.</given-names></name><name><surname>Wei</surname><given-names>D.G.</given-names></name><name><surname>Mamchak</surname><given-names>A.A.</given-names></name><name><surname>Terhorst</surname><given-names>C.</given-names></name><name><surname>Bendelac</surname><given-names>A.</given-names></name></person-group><year>2007</year><article-title>Homotypic interactions mediated by Slamf1 and Slamf6 receptors control NKT cell lineage development</article-title>.<source>Immunity.</source><volume>27</volume>:<fpage>751</fpage>&#x02013;<lpage>762</lpage><pub-id pub-id-type="pmid">18031695</pub-id></mixed-citation></ref><ref id="bib51"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nichols</surname><given-names>K.E.</given-names></name><name><surname>Hom</surname><given-names>J.</given-names></name><name><surname>Gong</surname><given-names>S.Y.</given-names></name><name><surname>Ganguly</surname><given-names>A.</given-names></name><name><surname>Ma</surname><given-names>C.S.</given-names></name><name><surname>Cannons</surname><given-names>J.L.</given-names></name><name><surname>Tangye</surname><given-names>S.G.</given-names></name><name><surname>Schwartzberg</surname><given-names>P.L.</given-names></name><name><surname>Koretzky</surname><given-names>G.A.</given-names></name><name><surname>Stein</surname><given-names>P.L.</given-names></name></person-group><year>2005</year><article-title>Regulation of NKT cell development by SAP, the protein defective in XLP</article-title>.<source>Nat. Med.</source><volume>11</volume>:<fpage>340</fpage>&#x02013;<lpage>345</lpage><pub-id pub-id-type="pmid">15711562</pub-id></mixed-citation></ref><ref id="bib52"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Komori</surname><given-names>H.</given-names></name><name><surname>Furukawa</surname><given-names>H.</given-names></name><name><surname>Mori</surname><given-names>S.</given-names></name><name><surname>Ito</surname><given-names>M.R.</given-names></name><name><surname>Terada</surname><given-names>M.</given-names></name><name><surname>Zhang</surname><given-names>M.C.</given-names></name><name><surname>Ishii</surname><given-names>N.</given-names></name><name><surname>Sakuma</surname><given-names>N.</given-names></name><name><surname>Nose</surname><given-names>M.</given-names></name><name><surname>Ono</surname><given-names>M.</given-names></name></person-group><year>2006</year><article-title>A signal adaptor SLAM-associated protein regulates spontaneous autoimmunity and Fas-dependent lymphoproliferation in MRL-Faslpr lupus mice</article-title>.<source>J. Immunol.</source><volume>176</volume>:<fpage>395</fpage>&#x02013;<lpage>400</lpage><pub-id pub-id-type="pmid">16365433</pub-id></mixed-citation></ref><ref id="bib53"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Steinberg</surname><given-names>A.D.</given-names></name><name><surname>Roths</surname><given-names>J.B.</given-names></name><name><surname>Murphy</surname><given-names>E.D.</given-names></name><name><surname>Steinberg</surname><given-names>R.T.</given-names></name><name><surname>Raveche</surname><given-names>E.S.</given-names></name></person-group><year>1980</year><article-title>Effects of thymectomy or androgen administration upon the autoimmune disease of MRL/Mp-lpr/lpr mice</article-title>.<source>J. Immunol.</source><volume>125</volume>:<fpage>871</fpage>&#x02013;<lpage>873</lpage><pub-id pub-id-type="pmid">7391583</pub-id></mixed-citation></ref><ref id="bib54"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ettinger</surname><given-names>R.</given-names></name><name><surname>Kuchen</surname><given-names>S.</given-names></name><name><surname>Lipsky</surname><given-names>P.E.</given-names></name></person-group><year>2008</year><article-title>The role of IL-21 in regulating B-cell function in health and disease</article-title>.<source>Immunol. Rev.</source><volume>223</volume>:<fpage>60</fpage>&#x02013;<lpage>86</lpage><pub-id pub-id-type="pmid">18613830</pub-id></mixed-citation></ref><ref id="bib55"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Odegard</surname><given-names>J.M.</given-names></name><name><surname>Marks</surname><given-names>B.R.</given-names></name><name><surname>Diplacido</surname><given-names>L.D.</given-names></name><name><surname>Poholek</surname><given-names>A.C.</given-names></name><name><surname>Kono</surname><given-names>D.H.</given-names></name><name><surname>Dong</surname><given-names>C.</given-names></name><name><surname>Flavell</surname><given-names>R.A.</given-names></name><name><surname>Craft</surname><given-names>J.</given-names></name></person-group><year>2008</year><article-title>ICOS-dependent extrafollicular helper T cells elicit IgG production via IL-21 in systemic autoimmunity</article-title>.<source>J. Exp. Med.</source><volume>205</volume>:<fpage>2873</fpage>&#x02013;<lpage>2886</lpage><pub-id pub-id-type="pmid">18981236</pub-id></mixed-citation></ref><ref id="bib56"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ettinger</surname><given-names>R.</given-names></name><name><surname>Sims</surname><given-names>G.P.</given-names></name><name><surname>Robbins</surname><given-names>R.</given-names></name><name><surname>Withers</surname><given-names>D.</given-names></name><name><surname>Fischer</surname><given-names>R.T.</given-names></name><name><surname>Grammer</surname><given-names>A.C.</given-names></name><name><surname>Kuchen</surname><given-names>S.</given-names></name><name><surname>Lipsky</surname><given-names>P.E.</given-names></name></person-group><year>2007</year><article-title>IL-21 and BAFF/BLyS synergize in stimulating plasma cell differentiation from a unique population of human splenic memory B cells</article-title>.<source>J. Immunol.</source><volume>178</volume>:<fpage>2872</fpage>&#x02013;<lpage>2882</lpage><pub-id pub-id-type="pmid">17312131</pub-id></mixed-citation></ref><ref id="bib57"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cappione</surname><given-names>A.</given-names><suffix>III</suffix></name><name><surname>Anolik</surname><given-names>J.H.</given-names></name><name><surname>Pugh-Bernard</surname><given-names>A.</given-names></name><name><surname>Barnard</surname><given-names>J.</given-names></name><name><surname>Dutcher</surname><given-names>P.</given-names></name><name><surname>Silverman</surname><given-names>G.</given-names></name><name><surname>Sanz</surname><given-names>I.</given-names></name></person-group><year>2005</year><article-title>Germinal center exclusion of autoreactive B cells is defective in human systemic lupus erythematosus</article-title>.<source>J. Clin. Invest.</source><volume>115</volume>:<fpage>3205</fpage>&#x02013;<lpage>3216</lpage><pub-id pub-id-type="pmid">16211091</pub-id></mixed-citation></ref><ref id="bib58"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Grammer</surname><given-names>A.C.</given-names></name><name><surname>Slota</surname><given-names>R.</given-names></name><name><surname>Fischer</surname><given-names>R.</given-names></name><name><surname>Gur</surname><given-names>H.</given-names></name><name><surname>Girschick</surname><given-names>H.</given-names></name><name><surname>Yarboro</surname><given-names>C.</given-names></name><name><surname>Illei</surname><given-names>G.G.</given-names></name><name><surname>Lipsky</surname><given-names>P.E.</given-names></name></person-group><year>2003</year><article-title>Abnormal germinal center reactions in systemic lupus erythematosus demonstrated by blockade of CD154-CD40 interactions</article-title>.<source>J. Clin. Invest.</source><volume>112</volume>:<fpage>1506</fpage>&#x02013;<lpage>1520</lpage><pub-id pub-id-type="pmid">14617752</pub-id></mixed-citation></ref><ref id="bib59"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Goodnow</surname><given-names>C.C.</given-names></name><name><surname>Sprent</surname><given-names>J.</given-names></name><name><surname>Fazekas de St Groth</surname><given-names>B.</given-names></name><name><surname>Vinuesa</surname><given-names>C.G.</given-names></name></person-group><year>2005</year><article-title>Cellular and genetic mechanisms of self tolerance and autoimmunity</article-title>.<source>Nature.</source><volume>435</volume>:<fpage>590</fpage>&#x02013;<lpage>597</lpage><pub-id pub-id-type="pmid">15931211</pub-id></mixed-citation></ref><ref id="bib60"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Allen</surname><given-names>C.D.</given-names></name><name><surname>Okada</surname><given-names>T.</given-names></name><name><surname>Cyster</surname><given-names>J.G.</given-names></name></person-group><year>2007</year><article-title>Germinal-center organization and cellular dynamics</article-title>.<source>Immunity.</source><volume>27</volume>:<fpage>190</fpage>&#x02013;<lpage>202</lpage><pub-id pub-id-type="pmid">17723214</pub-id></mixed-citation></ref><ref id="bib61"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Slingsby</surname><given-names>J.H.</given-names></name><name><surname>Norsworthy</surname><given-names>P.</given-names></name><name><surname>Pearce</surname><given-names>G.</given-names></name><name><surname>Vaishnaw</surname><given-names>A.K.</given-names></name><name><surname>Issler</surname><given-names>H.</given-names></name><name><surname>Morley</surname><given-names>B.J.</given-names></name><name><surname>Walport</surname><given-names>M.J.</given-names></name></person-group><year>1996</year><article-title>Homozygous hereditary C1q deficiency and systemic lupus erythematosus. A new family and the molecular basis of C1q deficiency in three families</article-title>.<source>Arthritis Rheum.</source><volume>39</volume>:<fpage>663</fpage>&#x02013;<lpage>670</lpage><pub-id pub-id-type="pmid">8630118</pub-id></mixed-citation></ref><ref id="bib62"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hutloff</surname><given-names>A.</given-names></name><name><surname>Buchner</surname><given-names>K.</given-names></name><name><surname>Reiter</surname><given-names>K.</given-names></name><name><surname>Baelde</surname><given-names>H.J.</given-names></name><name><surname>Odendahl</surname><given-names>M.</given-names></name><name><surname>Jacobi</surname><given-names>A.</given-names></name><name><surname>Dorner</surname><given-names>T.</given-names></name><name><surname>Kroczek</surname><given-names>R.A.</given-names></name></person-group><year>2004</year><article-title>Involvement of inducible costimulator in the exaggerated memory B cell and plasma cell generation in systemic lupus erythematosus</article-title>.<source>Arthritis Rheum.</source><volume>50</volume>:<fpage>3211</fpage>&#x02013;<lpage>3220</lpage><pub-id pub-id-type="pmid">15476242</pub-id></mixed-citation></ref><ref id="bib63"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hutloff</surname><given-names>A.</given-names></name><name><surname>Dittrich</surname><given-names>A.M.</given-names></name><name><surname>Beier</surname><given-names>K.C.</given-names></name><name><surname>Eljaschewitsch</surname><given-names>B.</given-names></name><name><surname>Kraft</surname><given-names>R.</given-names></name><name><surname>Anagnostopoulos</surname><given-names>I.</given-names></name><name><surname>Kroczek</surname><given-names>R.A.</given-names></name></person-group><year>1999</year><article-title>ICOS is an inducible T-cell co-stimulator structurally and functionally related to CD28</article-title>.<source>Nature.</source><volume>397</volume>:<fpage>263</fpage>&#x02013;<lpage>266</lpage><pub-id pub-id-type="pmid">9930702</pub-id></mixed-citation></ref><ref id="bib64"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rasheed</surname><given-names>A.U.</given-names></name><name><surname>Rahn</surname><given-names>H.P.</given-names></name><name><surname>Sallusto</surname><given-names>F.</given-names></name><name><surname>Lipp</surname><given-names>M.</given-names></name><name><surname>Muller</surname><given-names>G.</given-names></name></person-group><year>2006</year><article-title>Follicular B helper T cell activity is confined to CXCR5(hi)ICOS(hi) CD4 T cells and is independent of CD57 expression</article-title>.<source>Eur. J. Immunol.</source><volume>36</volume>:<fpage>1892</fpage>&#x02013;<lpage>1903</lpage><pub-id pub-id-type="pmid">16791882</pub-id></mixed-citation></ref><ref id="bib65"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Phan</surname><given-names>T.G.</given-names></name><name><surname>Amesbury</surname><given-names>M.</given-names></name><name><surname>Gardam</surname><given-names>S.</given-names></name><name><surname>Crosbie</surname><given-names>J.</given-names></name><name><surname>Hasbold</surname><given-names>J.</given-names></name><name><surname>Hodgkin</surname><given-names>P.D.</given-names></name><name><surname>Basten</surname><given-names>A.</given-names></name><name><surname>Brink</surname><given-names>R.</given-names></name></person-group><year>2003</year><article-title>B cell receptor-independent stimuli trigger immunoglobulin (Ig) class switch recombination and production of IgG autoantibodies by anergic self-reactive B cells</article-title>.<source>J. Exp. Med.</source><volume>197</volume>:<fpage>845</fpage>&#x02013;<lpage>860</lpage><pub-id pub-id-type="pmid">12668643</pub-id></mixed-citation></ref></ref-list><fn-group><fn><p>Abbreviations used: ANA, antinuclear antibody; dsDNA, double-stranded DNA; GC, germinal center; H&#x00026;E, hematoxylin and eosin; HEL, hen egg lysozyme; miRNA, microRNA; SHM, somatic hypermutation; SLE, systemic lupus erythematosus; SRBC, sheep red blood cell; T<sub>FH</sub>, follicular helper T.</p></fn></fn-group></back></article>